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Abstract 
Disease management is crucial in the aquaculture industry and to date it 
involves the usage of antibiotics to treat and prevent disease, especially bacterial 
infections. However, there is a growing concern over the problems caused by 
conventional antibiotics in aquatic and terrestrial environments (eg, bacteria resistant 
to multiple antibiotics). Therefore, it is crucial to reduce the usage of conventional 
antibiotics or find alternative novel antibacterial agents to manage bacterial diseases 
and antibiotic-resistant bacteria. Antimicrobial peptides are natural antibiotics 
produced from multicellular organisms and have the ability to kill bacteria and to 
synergise with other antibiotics. In this study I have analysed the in-vitro antibacterial 
activity of synthetic Atlantic cod piscidin and its ability to permeabilize the bacterial 
membrane. Moreover, I have investigated the antimicrobial properties of synthetic cod 
piscidin in combination with several conventional antibiotics, including oxolinic acid, 
oxytetracycline hydrochloride, and sulfadiazine/trimethoprim, which are amongst the 
most important groups of antibiotics for prevention of bacterial diseases in 
aquaculture. Five test bacteria, including two Gram-positive bacteria (Micrococcus 
lysodeikticus and Planococcus citreus) and three Gram-negative bacteria (Yersinia 
ruckeri VI 3629, Vibrio anguillarum VI-F-258-3 and Aeromonas salmonicida NCIMB 
1102) were tested for synergistic activity of peptide-antibiotic combination. 
Antibacterial activity results showed moderate synergism i) between oxolinic acid and 
synthetic cod piscidin against V. anguillarum VI-F-258-3; ii) combined 
oxytetracycline hydrochloride and synthetic cod piscidin against V. anguillarum VI-F-
258-3 and A. salmonicida NCIMB 1102; iii) and combined sulfadiazine/trimethoprim 
and synthetic cod piscidin against M. lysodeikticus, A. salmonicida NCIMB 1102, Y. 
ruckeri VI 3629. In contrast, no synergistic activity of either test antibiotics with 
synthetic cod piscidin was found against P. citreus. The data show that synthetic cod 
piscidin can reduce the concentration of conventional antibiotics required to inhibit 
bacterial growth of fish pathogenic bacteria, namely Y. ruckeri VI 3629, V. 
anguillarum VI-F-258-3 and A. salmonicida NCIMB 1102. Flow cytometry analysis 
revealed that this peptide could form stable pores in the bacterial membrane, which 
might be its main mechanism of action. These properties of synthetic cod piscidin 
highlight its potential an novel antibacterial agent that in a not so distant future may be 
used in disease control management in commercial aquaculture systems. 
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Chapter 1. Introduction 
1.1. Status of cod farming 
1.1.1. Aquaculture industry 
Atlantic cod (Fig. 1) is a marine cold-water fish species, which is demersal and 
distributed in the North Atlantic from inshore regions to deeper waters. This fish is 
omnivorous and while young fish feed on plankton and small invertebrates (such as 
crustaceans, polychaetes, and echinoderms), adults feed on invertebrates, fish and 
occasionally seaweeds (Cohen et al., 1990). 
 
Figure 1. Atlantic cod, Gadus morhua Linnaeus 1758 (FAO, 2010). 
Nowadays, Atlantic cod is important for the aquaculture industry, especially in 
Norway, where it is a relatively new commercially farmed species (Grave et al., 2008). 
According to FAO, the global Atlantic cod capture has decreased steadily since 1968 
until 2007 while its global aquaculture production has increased from 2001 until 2007 
(Fig. 2) (FAO, 2010). Moreover, Norwegian aquaculture production of Atlantic cod 
has increased during the period 2000-2005 along with the usage of antimicrobial 
agents used in Norwegian aquaculture of Atlantic cod (Grave et al., 2008).  
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Figure 2. The global capture (A) and aquaculture production (B) for Atlantic cod 
(Gadus morhua) (FAO, 2010). 
1.1.2. Atlantic cod diseases 
Atlantic cod farming has traditionally been affected by bacterial diseases 
caused by two dominant pathogens, including Vibrio sp. and Aromonas spp. 
(Samuelsen et al., 2006). Vibriosis is the most serious diseases that caused by Vibrio 
sp. (eg. Vibrio anguillarum). Head and eyes are the main target organs of infection and 
this disease has clinical signs such as fin erosion and haemorrhages. Aeromonas 
salmonicida, the causative agent of furunculosis in Atlantic salmon, also infects 
Atlantic cod. The clinical signs include haemorrhages and necrosis of several organs, 
such as gills and skin (Samuelsen et al., 2006). Importantly, francisellosis is a new 
serious bacterial disease affecting Atlantic cod in Norway (Nylund et al., 2006). This 
disease is caused by Fracisella sp. and is characterized by haemorrahagic nodules in 
the skin and swollen kidney and spleen (Olsen et al., 2006). Therefore, antimicrobial 
agents (e.g., antibiotics) are necessary to manage the pathogenic bacteria invading 
Atlantic cod in aquaculture and preventing disease outbreaks that cause huge economic 
losses. 
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1.2. Antibiotics 
The most common compounds used in health management in aquaculture are 
antibiotics. An antibiotic is a biologically or synthetically produced substance 
(Graslund and Bengtsson, 2001) that has the ability to destroy bacteria or inhibit the 
bacterial growth (Sapkota et al., 2008). There are many different common groups of 
antibiotics including tetracyclines, quinolones, sulphonamides, aminopyrimidines, and 
amphenicols that are applied in aquaculture worldwide (Grave et al., 2008; Samuelsen 
et al., 2006; Schmidt et al., 2000). In particular, oxytetracycline, oxolinic acid, and 
combination of sulfadiazine with trimethoprim are the most commonly used antibiotics 
in Norwegian aquaculture (Sapkota et al., 2008). These antibiotic agents can protect 
cultured fish from bacterial infections to some extent but nowadays there are growing 
concerns with antibiotic-resistant bacteria. This issue has intensified to search for 
novel antimicrobial agents that can be used as alternative to antibiotics to treat and 
prevent bacterial diseases, whilst having less or no negative effect to other organisms 
in the environments surrounding aquaculture system. 
1.2.1. Main groups of antibiotics used in aquaculture and 
their mechanisms 
1.2.1.1. Quinolones are the group of antibiotics most commonly used in aquaculture. 
In particular, oxolinic acid is one antibiotic in this group that is widely applied to treat 
and prevent bacterial diseases in cultured commercial fish. It is a weak acid soluble in 
alkaline solution (Samuelsen et al., 1992) that is of synthetic origin and mainly used 
against Gram-negative bacteria, which it destroys by inhibiting their DNA-metabolism 
(Graslund and Bengtsson, 2001). These antibiotics  binding to complexes between 
DNA and gyrase or topoisomerase IV, leading to changes in the enzyme conformation. 
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The resulting quinolone-gyrase-DNA complex then inhibits DNA replication 
(Hawkey, 2003). 
1.2.1.2. Sulfonamides belong to an antibiotic group that is usually used in 
combination with trimethoprim against both Gram-negative and Gram-positive 
bacteria by a two step mechanism. In the first step, they impair tetrahydrofolate 
synthesis by inhibiting p-aminobenzoic acid, which leads to a decrease in nucleotide 
levels and in the second step they inhibit dihydrofol acid reductase, ultimately resulting 
in inhibition of bacterial growth (Graslund and Bengtsson, 2001; Vitale et al., 2003). 
1.2.1.3. Tetracyclines are normally used in aquaculture to control bacterial diseases in 
salmonids, namely furunculosis. Oxytetracycline is usually used in aquaculture, since 
it has broad-spectrum activity against a wide range of Gram-negative or Gram-positive 
bacteria. These antibiotics inhibit protein synthesis (Graslund and Bengtsson, 2001) by 
protecting the aminoacyl tRNA and the ribosomes of bacteria (Chopra and Roberts, 
2001). 
1.2.2. The negative effect of antibiotics 
1.2.2.1.Antibiotic-resistant bacteria 
Normally antibiotic-resistant bacteria arise by DNA mutations as well as by 
horizontal gene transfer mechanisms such as conjugation, conjugative transposition 
(Cabello, 2006) and transduction with other bacteria (Sapkota et al., 2008). For 
example, oxolinic acid works by constraining the DNA-metabolism of bacteria but 
unfortunately oxolinic acid-resistant bacteria are able to repair the damaged DNA due 
to resistance mutations (Graslund and Bengtsson, 2001). Plasmid-mediated and 
plasmid-transmitted resistance (Graslund and Bengtsson, 2001) are common for 
sulfonamides and tetracycline, and trimethoprim resistances genes are found in 
plasmids of both Gram-negative and Gram-positive bacteria (Sorum and L'Abee-Lund, 
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2002). Moreover, it has been reported that oxytetracycline-resistance plasmids can be 
transferred from fish pathogenic bacteria (Aeromonas) to human Escherichia coli 
(Rhodes et al., 2000). This is a very clear example of how resistance genes from 
antibiotics resistant bacteria in aquatic environments can be transferred to terrestrial 
bacterial, which might lead to antibiotic resistant bacteria in the terrestrial 
environment. 
1.2.2.2. The antibiotics residues accumulation 
The leaching of antibiotics from uneaten feed, excretion of actives metabolites, 
and excessive usage of antibiotics can be deposited in sediments on the bottom of the 
pond, river or sea bed and lead to accumulation of antibiotics residues for long periods 
of the time. As the antibiotics residues diffuse into the sediment, some of them can be 
digested by aquatic organisms but the remaining antibiotic residues can induce 
antibiotic-resistant bacteria amongst the normal microflora in the sediment (Cabello, 
2006). Antibiotic residues accumulate not only in the sediment but also distribute 
throughout the water column. These residues are in fact rich nutrients for growing 
plankton. The rapid growing of plankton due to high nutrient uptake leads to 
eutrophication, inducing changes in the ecological equilibrium (eg, producing an 
anoxic environment that has a negative impact to aquatic and terrestrial organisms 
(Chopra and Roberts, 2001)). In another study of antibiotic residues conducted in 
Norway, oxolinic acid residues have been detected in liver, plasma, and muscle of wild 
fish and crab; the source of this antibiotic residues was the medication administered in 
fish farms (Samuelsen et al., 1992). From these supporting reports, antibiotics residues 
from aquaculture activity in water column and sediment have negative impact directly 
to wild fauna and flora in aquatic environment. Therefore, it is necessary to find 
alternative antibiotics to use in the aquaculture industry. 
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1.3. Antimicrobial peptides and their mode of action 
Antimicrobial peptides are natural antibiotics produced by multicellular 
organisms, including plants, insects, amphibians, teleosts and mammals (McCafferty et 
al., 1999) (Fig. 3). They are low molecular weight compounds that consist of less than 
100 amino acids (Smith and Fernandes, 2009) and they have frequently been proposed 
as alternative anti-infective agents (Hancock, 1997). Antimicrobial peptides have been 
isolated from different cells, tissues and secretions from vertebrates, e.g., skin of 
rainbow trout (Fernandes and Smith, 2002), human urine (Park et al., 2001), epidermal 
mucus of Atlantic cod (Bergsson et al., 2005) and mast cells of hybrid striped bass 
(Silphaduang and Noga, 2001). Antimicrobial peptides are crucial components in 
innate defense against microbes (Boman, 1998), which is an important host defense 
mechanism for most living organisms both in terrestrial and aquatic environments but 
especially for aquatic organisms, which inhabit a complex environment rich in 
potential pathogens. Fish possess a diverse suite of antimicrobial peptides and these 
may play a more substantial role in the innate immune system of fish when compared 
to terrestrial mammals, which have a more highly evolved adaptive immune system 
(Douglas et al., 2003). Fish antimicrobial peptides have been isolated from different 
species (Table 1) and can be grouped in five families, based on their homology, 
secondary structure and genomic organization, including: the cathelicidins, defensins, 
LEAPs, piscidins and histone-dirived peptides (Smith and Fernandes, 2009). 
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Table 1. Antimicrobial peptides (AMPs) isolated from different species of fishes. 
AMPs Species of fish References 
CATH-1, -2 Rainbow trout 
(Oncorhynchus mykiss) 
Chang et al. (2005) 
CATH-1, -2 Atlantic salmon 
(Salmo salar) 
Chang et al. (2006) 
Histone H1 Coho salmon 
(Oncorhynchus kisutch) 
Patrzykat et al. (2001) 
Histone H2A Rainbow trout 
(Oncorhynchus mykiss) 
Fernandes et al. (2002) 
Histone H2B Atlantic cod 
(Gadus morhua) 
Bergsson et al. (2005) 
Piscidins Hybrid striped bass                  
(Morone chrysops x Morone saxatilis) 
Silphaduang and Noga, 
(2001) 
Pleurocidins Atlantic halibut 
(Hippoglossus hippoglossus) 
Patrzykat et al.(2003) 
Moronecidins Striped bass 
(Morone saxatilis) 
Lauth et al.(2002) 
Ribosomal Atlantic cod 
(Gagus morhua) 
Bergsson et al.(2005) 
Hepcidins Winter flounder                
(Pleuronectes americanus) 
Douglas et al.(2003) 
Hepcidin Hybrid striped bass                  
(Morone chrysops x Morone saxatilis) 
Lauth et al.(2005) 
Parasin I Amur catfish 
(Parasilurus asotus) 
Park et al.(1998b) 
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Antimicrobial peptides kill microbes through different mechanisms, namely by 
depolarizing and permeabilizing bacterial cell membrane, disrupting cell metabolism 
or interfering with DNA synthesis (Smith and Fernandes, 2009). The most common 
mode of action of antimicrobial peptides is explained by their ability to disrupt outer 
membrane of Gram-positive and Gram-negative bacteria by forming channels in the 
cytoplasmic membrane (Fig. 4). Typically, an antimicrobial peptide containing 
positively charged residues has the ability to interact with the negatively charged 
phospholipid heads on the bacterial membranes, their hydrophobic faces directed 
towards the bacterial membrane interior and their hydrophilic faces pointing inwards to 
form a channel that leads to release of intracellular components and causing bacterial 
cell dead (Hancock, 1997; Hancock and Chapple, 1999; Hancock and Scott, 2000). 
 
Figure 3. Several cationic antimicrobial peptides. 
Red is the Basic amino acids (positively charged) are coded red, whereas hydrophobic 
amino acids are shown in green (Zasloff, 2002). 
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Figure 4. Mechanism of action of cationic peptides through pore formation . 
Positively charged antimicrobial peptides bind the negatively charged phospholipids 
head groups in the bacterial cytoplasmic membrane. This interaction results in the 
formation of pores on the bacterial membrane, which then leads to leakage of ions and 
the intracellular contents of the bacterial cell (Hancock, 1997). 
1.3.1. Piscidin antimicrobial peptide. 
 Piscidins are antimicrobial peptides composed of approximately 22 amino acid 
residues that have been found just only fish. They are characterized a by conserved 
amino-terminus rich in histidine and phenylalanine and the mature peptides have a 
high positive net charge at physiological pH. (Chekmenev et al., 2006; Fernandes et 
al., 2010; Silphaduang and Noga, 2001; Sung et al., 2008). Sun et al. (2007) reported 
that the mandarin fish piscidin contained four exons and three introns that coded for a 
prepropeptide consisting of a signal peptide 22 amino acid, 22 amino acids of a mature 
peptide (contained high positively charge) and 35 amino acids of a C-terminal 
prodomain that is similar to the moronecidin gene from hybrid striped bass (Lauth et 
al., 2002) (Fig. 5). There are many peptide members in this family, including 
pleurocidin, piscidins, chrysophsins, epinecidin-1 and dicentracin, which are grouped 
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as piscidins based on their similarities in genomic organization, amino acid sequence, 
secondary structure and phylogeny. Piscidin displays broad-spectrum activity against 
bacteria, fungus, protozoan parasites and even some enveloped virus (Smith and 
Fernandes, 2009). The piscidins are amphipathic cationic peptides that contain highly 
positively charge and also hydrophobic side chains in a linear α-helical structure (Fig. 
6) that can be interact with the bacterial membrane through a similar mechanism to 
that of most antimicrobial peptides, leading to pore formation in the bacterial 
membrane followed by release of the intracellular contents (Fernandes et al., 2010; 
Noga et al., 2009). Piscidins have been found in the skin, intestine and gills (Cole et 
al., 2000; Cole et al., 1997; Lauth et al., 2002; Mulero et al., 2008), which are the 
mucosal tissues that exposed with pathogens in aquatic environment all the time. 
Therefore, piscidins are likely to play an important role in the first defence barrier 
against pathogen invasion in fish. 
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Figure 5. Bass moronecidin (piscidin) gene organization (Lauth et al., 2002). 
 
Figure 6. Amphipathic α-helical structure of piscidin from Atlantic cod (Gadus 
morhua). The hydrophilic residues are gray pentagons and hydrophobic residues are 
green diamonds. While the circles are neutral or polar amino acids (Fernandes et al., 
2010). 
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1.4. Synergistic activity 
Synergistic activity is defined as the combined positive interaction of two or 
more antimicrobial agents towards a single target molecule (McCafferty et al., 1999). 
The advantages of antimicrobial peptides over conventional antibiotics for therapeutic 
treatment are that they have broad spectrum for antibacterial, fungal and viral infection 
(Giacometti et al., 2000b) and they can synergise with other antibiotics (Cirioni et al., 
2006; Giacometti et al., 2000b; Park et al., 2006) and antimicrobial peptides (Lauth et 
al., 2005; Patrzykat et al., 2001) to enhancing their antimicrobial activity . to kill 
multiple-resistant strains of bacteria (Marr et al., 2006). The synergistic activity is 
evaluated by using fractional inhibitory concentration (FIC) index,  
FIC = FICA+FICB= [A]/ MICA+[B]/ MICB  
Where [A] and [B] are the minimal inhibitory concentration (MIC) of drug A and drug 
B in the combination, MICA and MICB are the MIC of drug A and drug B alone, and 
FICA and FICB are the FIC of combined drug A and drug B.  
The FIC index is interpreted as follow: ≤0.5, good synergism; 1.0, additive; and 
>4.0, antagonism (Yan and Hancock, 2001). Synergism is a positive interaction, 
inasmuch as antimicrobial activity of combined antimicrobial agents show 
significantly greater than their individual activity when tested separately. Additively is 
the result that shows antimicrobial activity of combined agents show no significant 
interaction when compared with individual activity when tested separately. On the 
other hand, antagonism is a negative interaction that antimicrobial activity of 
combined antimicrobial agents shows significantly less than their individual activity 
when tested separately. (Amsterdam, 2005). 
This study focused on the synergistic potential of combining synthetic cod 
piscidin and conventional antibiotics to enhance their antibacterial activity in vitro  
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1.5. Main objectives 
1. To purify and characterize synthetic cod piscidin. 
2. To determine its spectrum of activity. 
3. To investigate the kinetics of killing of synthetic cod piscidin. 
4. To determine its haemolytic properties against cod erythrocytes. 
5. To investigate if synthetic cod piscidin can disrupt the bacterial membranes through 
pore formation. 
6. To ascertain if synthetic cod piscidins can potentiate the activity of other 
antibacterial compounds. 
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Chapter 2. Synthetic piscidin from Atlantic Cod 
(Gadus morhua L.) and its potential 
2.1. Materials and methods 
2.1.1. Sequence analysis 
 The protein sequences of teleosts piscidins were obtained from Gene bank of 
National Center for Biotecnology Information (NCBI) database 
(http://www.ncbi.nlm.nih.gov/) and then aligned with the ClustalW 
(http://align.genome.jp/) and performed the multiple sequence alignment by using 
BioEdit. Nine protein sequences of piscidins from difference teleost species (Table 2) 
including Atlantic cod were constructed the phylogenetic tree by Maximum likelihood 
using ATGC: Montpellier bioinformatics platform (PhyML, http://www.atgc-
montpellier.fr/phyml/) and performed the phylogenetic tree by MEGA 4. 
Table 2. The Gene bank of protein sequences of piscidin from teleost fishes that 
were obtained from NCBI database. 
Teleost species Gene Gene bank 
Gadus morhua Piscidin ACS91329.1 
Morone chrysops x Morone saxatilis Piscidin 3 P0C006.1 
Epinephelus fuscoguttatus Piscidin-like peptide ADE06665.1 
Epinephelus coioides Piscidin-like peptide ACE78291.1 
Epinephelus akaara Piscidin-like peptide ACE78290.1 
Larimichthys crocea Piscidin-like peptide ACE78289.1 
Siniperca chuatsi Moronecidin AAV65044.1 
Morone chrysops Moronecidin AAL40409.1 
Morone saxatilis Moronecidin Q8UUG0.1 
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2.1.2. Peptide synthesis 
The piscidin sequence, FIHHIIGWISHGVRAIHRAIHG was characterized 
from Atlantic cod by Ms Jareeporn Ruangsri, a doctoral student in Aquatic Animal 
Health and Welfare, Faculty of Biosciences and Aquaculture, Bodø University College 
(Ruangsri et al. unpublished). The synthetic cod piscidin was synthesized by Gen 
Script (The Biology CRO, USA) by using the mentioned sequence. The theoretical 
molecular weight was 2527 Da. 
2.1.3. Peptide purification 
2.1.3.1. High performance liquid chromatography 
The synthesized peptide was chromatographed by C18 reversed-phase HPLC 
using 0.1% trifluoroacetic acid (TFA) in distilled water (solution A) and 0.1% TFA in 
acetonitrite (solution B). The synthesized peptide was dissolved in 0.1% TFA in 
distilled water and filtered with 0.2 µm pore filter (Whatman International Ltd, 
England) before purified by HPLC. One hundred microliter of sample was injected 
onto the column and eluted with solution A and solution B at a flow rate of 1 ml/min. 
The column was washed and equilibrated with both buffer solutions until no peptides 
remained in the column that was detected by absorbance at 280 nm. After HPLC, the 
interested fractions were lyophilized by freeze dryer until the solution was removed 
and then dry material was resuspended in 0.01% acetic acid in distilled sterile water 
and kept in -80°C until used for sodium dodecylsulfate polyacrylamind gel 
electrophoresis (SDS-PAGE) and antibacterial activity assays. 
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2.1.4. Sodium dodecylsulfate polyacrylamind gel electropho-
resis (SDS-PAGE) 
The synthetic cod piscidin purification was modified from Fernandes and 
Smith (2002) base on Schagger and Vonjagow (1987) by using SDS-PAGE with the 
Tris-Tricine system, 16% separating gel, 14% spacer gel, and 5% stacking gel (the gel 
preparation is followed Table 3). The three gel layers were separated following 
separating gel high approximately 4.5 cm, spacer gel 1.5 cm, and stacking gel 1 cm. 
The purified peptide each interested fraction was prepared by mixing with 
protein loading buffer (0.61 % (w/v) Tris, 4% (w/v) SDS, 12% (w/v) glycerol, 0.01% 
(w/v) bromophenol blue, 2% (v/v) β-mercaptoethanol, pH 6.8), purified peptide : 
protein loading buffer = 1 : 1 and then denatured by heating at 95 °C for 5 min. The 
low molecular weight protein marker (New England BioLab, USA) in range 3.4-212 
kDa was used. Anode (2.42 % (w/v) Tris, pH 8.90) and cathode (1.21 % (w/v) Tris, 
1.79% (w/v) Tricine (BDH), 0.1% (w/v) SDS, pH 8.25) buffer were put in the 
electrophoresis chambers (BioRad, USA). Six microliter of marker was added into the 
first well and followed by the 20 µl of complex sample in stacking gel. The gels were 
run in a Mini-PROTEIN® Tetra cell electrophoresis (BioRad, USA) approximately for 
2.30 h. (until the space between sample and end of separating gel was 1 cm) at 
constant current of 100 volt. The gels were stained with the coomassie staining (0.25 
% (w/v) Coomassie brilliant blue R250, 45 % (v/v) methanol and 10 % (v/v) glacial 
acetic acid) for 30 min and following by immersed in destaining solution (25 % (w/v) 
methanol and 7.5 % (w/v) acetic acid) until show clearly blue band of protein marker 
in the gel. 
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Table 3. The details of polyacrylamind gel preparation. 
Compositions Separating gel Spacer gel Stacking gel 
40 % Acrylamind:Bis (29:1), 
Accugel (ml) 
3.1 0.77 0.62 
Gel buffer (ml) (36.33% (w/v) 
Tris, 0.3 % (w/v) SDS, pH 8.45) 
2.5 1.0 1.55 
Water (ml) 0.65 1.23 4.08 
80% (w/v) Glycerol (ml) 1.25 - - 
10% (w/v) APS (µl) 75 30 100 
TEMED (µl) 7.5 3.0 10.0 
Approximately total volume 7.5 3.0 6.25 
This gel preparation for 16% separating gel, 14% spacer gel and 5% stacking gel that 
enough for 2 gels (separating gel 4.5 cm, spacer gel 1.5 cm, and stacking gel 1 cm) 
(Fernandes, 2002). 
2.1.5. MALDI-TOF MS 
The purified peptide fractions were collected based on antibacterial activity 
assay (two layer radial diffusion) of active fractions and approximately molecular mass 
by SDS-PAGE polyacrylamind gel electrophoresis (the theoretical molecular weight 
was 2527 Da). The molecular mass of collected fractions were determined by MALDI 
Micro MX (Waters/Micromass) using a nitrogen laser of 337 nm at the University of 
Tromsø, Norway. Each sample was mixed 1:1 with α-cyano-4-hydroxycinnamic acid. 
Glufibrinopeptide B was used as internal standard for mass adjustment (peptide mass, 
1570.67 Da). 
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2.1.6. Protein quantification 
The purified synthetic cod piscidin was measured the concentration by using a 
Quant-iTTM protein assay kit (Invitrogen, U.S.A) following the manufacturer’s 
protocol. Briefly, the working solution was prepared by diluting the Quant-iTTM 
reagent 1:200 in Quant-iTTM buffer. Three standards solution were used for 
calibrations; 10 µl of each standard solution was mixed with 190 µl of working 
solution in 0.5 ml PCR tube. Ten microliters of sample was added in 0.5 ml PCR tube 
and followed by adding 190 µl of working solution. The standards and samples were 
incubated for 15 min at room temperature and then the standards were equilibrated and 
followed by determining of protein concentration of the samples by QubitTM 
fluorometer (Invitrogen, U.S.A). 
2.1.7. Antibacterial activity 
2.1.7.1. Test bacteria 
2.1.7.1.1. Culture condition 
The various 12 bacterial strains including 4 Gram-positive bacteria and 8 
Gram-negative bacteria (Table 5) were kindly given by Ms Jareeporn Ruangsri, a 
Ph.D. student in Aquatic Animal Health and Welfare at Bodø university college, 
Norway. All test bacterial strains were cultured under appropriate condition based on 
Fernandes et al. (2002) and Ruangsri et al. (In press). All bacterial strains were 
cultured in trypticase soy broth (TSB) (Merck KGaA, Darmstadt, Germany) or 
trypticase soy agar (TSA) (Fluka Analytical, Switzerland), supplemented with NaCl 
(Merck KGaA, Darmstadt, Germany) as appropriate that were prepared following the 
manufacturer’s protocol (Table 4) and incubated at appropriate temperature which is 
showed in Table 5. 
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Table 4. The preparation of trypticase soy broth and agar. 
Trypticase Soy Broth Trypticase Soy Agar 
Ingredients Supplemented 
with 0.85% 
NaCl 
Supplemented 
with 1.5% 
NaCl 
Supplemented 
with 0.85% 
NaCl 
Supplemented 
with 1.5% 
NaCl 
Distilled water (ml) 1,000 1,000 1,000 1,000 
Trypticase Soy Broth (g) 30 30 30 30 
NaCl (g) 8.5 15 8.5 15 
Agar (g) - - 15 15 
Directions: All ingredients are suspended in glass bottle and sterilized at 121 °C for 15 
minutes by autoclaving, cool to 40-45 °C and poured in sterile Petri dishes for 
trypticase soy agar. The broth and agar media were kept in 4°C until use. 
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Table 5. List of the bacteria, identification code, and their culture conditions. 
Bacteria Gram Culture media+%NaCl/temperature condition 
Micrococcus lysodeikticus  + Trypticase soy agar or broth+0.85% NaCl / 37oC 
Planococcus citreus  + Trypticase soy agar or broth +1.5% NaCl / 20oC 
Staphylococcus aureus ATCC 9144 + Trypticase soy agar or broth+0.85% NaCl / 37oC 
Corynebacterium glutamicum ATCC 13032 + Trypticase soy agar or broth+0.85% NaCl / 25oC 
Escherichia coli ATCC 25922 - Trypticase soy agar or broth+0.85% NaCl / 37oC 
Vibrio anguillarum NCIMB 2133  - Trypticase soy agar or broth +1.5% NaCl / 20oC 
Vibrio anguillarum VI-F-258-3  - Trypticase soy agar or broth +1.5% NaCl / 20oC 
Vibrio anguillarum  - Trypticase soy agar or broth +1.5% NaCl / 20oC 
Aeromonas salmonicida NCIMB 1102  - Trypticase soy agar or broth +1.5% NaCl / 20oC 
Yersinia ruckeri NCIMB 2196  - Trypticase soy agar or broth +1.5% NaCl / 20oC 
Yersinia ruckeri VI 3629  - Trypticase soy agar or broth +1.5% NaCl / 20oC 
Psychrobacter immobilis  - Trypticase soy agar or broth +1.5% NaCl / 20oC 
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2.1.7.1.2. Growth curve determination 
The bacterial strains in the Table 5 were sub-cultured onto TSA (suplemented 
NaCl as appropriate) under aseptic technique and incubated overnight at optimal 
temperature. Then several freshly colonies were picked and inoculated in the 
Erlenmeyer flasks (100 ml) containing 50 ml of TSB (supplemented NaCl as 
appropriate). The flasks were incubated at appropriate temperature condition (Table 5) 
with constant shaking for 200 rpm. The suspended bacterial cells in TSB were 
determined the optical density at 600 nm (Perni et al., 2005) by using 
spectrophotometer each indicated times after incubation until the growth curve of each 
bacteria reach to stationary phase. The optimal density each indicated times were 
performed in triplicate and then the average values were plotted with particular times 
to show the growth curve of each bacterial strain. 
2.1.7.1.3. Cell density determination 
In this experiment, all 12 bacterial stains (Table 5) were determined density 
(CFU/ml) by plating on TSA (supplemented NaCl as appropriate) at different 
concentration of bacterial suspension based on optical density at 600 nm. Drop plate 
method was modified from Herigstad et al. (2001) and applied to determine the 
bacterial cell density in this experiment. The bacteria on TSA from a freshly overnight 
culture were inoculated into the Erlenmeyer flasks (100 ml) that contained 50 ml of 
TSB and incubated at appropriate temperature (Table 5) with constant shaking for 200 
rpm until reach to exponential phase. Then, the bacterial suspension in TSB was varied 
concentrations by diluting in the same medium and followed by measuring optimal 
density at 600 nm. Ten-fold serial dilution was made from each concentration of 
bacteria suspension with TSB. Thirty microliters of diluted bacterial suspension was 
plated on the TSA (supplemented NaCl as appropriate) for triplicate, overnight 
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incubated at optimal temperature. The bacterial colonies on agar plate in range 30-300 
colonies were considered as standard number for counting under a phase contrast 
stereo microscope. The counted bacterial cells were calculated as the number of colony 
forming unit (CFU) per milliliter of culture media after correcting for dilutions. The 
bacterial cell density (CFU/ml) at particular optical density at 600 nm was plotted to 
show the relationship and the linear regression equation was obtained. Finally the 
bacterial density at 108 CFU/ml at optical density 600 nm was calculated by using 
linear regression equation which is the relationship of bacterial density (CFU/ml) and 
optical density at 600 nm. 
2.1.7.2. Antimicrobial assay by two layer radial diffusion for selecting 
active fraction of synthetic cod piscidin after purification by HPLC 
The two-layer radial diffusion method was modified from Smith et al. (2000) 
used for first screen of antibacterial activity of purified synthetic cod piscidin of each 
interested fractions after HPLC purification. The Gram-positive bacterium P. citreus 
was used for testing antibacterial activity of purified peptide in this assay. Briefly, 144 
cm2 square petri-dish was added 14 ml bacterial underlayer, consisted 1.5% NaCl, 1% 
bactotryptone, 0.5% yeast extract and 1% agarose in the distilled water and 2×106 
CFU/ml of washed bacterium cells (log phase), and the underlayer was holed for 3 mm 
diameter by sterile pipette. Three microliters of interested fraction of the purified 
peptide was added into each well for duplicates and the control was 0.01 % acetic acid 
in sterile distilled water which is the diluent of sample. The plate was incubated at 4°C 
for 3 hours and then covered with 14 ml upperlayer, contained 6% TSB, 1.5% NaCl 
and 1% agarose and then incubated at 20 °C for 12-24 hours. The diameter of clear 
zone area (mm2) in the underlayer agar was indicated antibacterial activity of each 
well. 
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2.1.7.3. Antibacterial activity by microtitre broth dilution assay for 
determination of minimal inhibitory concentrations (MICs) and 
plating for minimal bactericidal concentration (MBC) of purified 
synthetic cod piscidin 
2.1.7.3.1. Preparation of bacterial cells for antibacterial activity assays 
Twelve bacterial strains in Table 5 were prepared for the antibacterial activity 
assays of purified antibacterial peptide. Briefly, the freshly overnight bacterial colonies 
on TSA were inoculated in 50 ml of TSB, contained 1.5% or 0.85% NaCl as 
appropriate and incubated at optimal temperature (Table 5) with constant shaking 200 
rpm until reached to exponential phase. The bacterial suspension was transferred into 
50 ml sterile centrifuge tube and centrifuged (Heraeus Labofuge 400R centrifuge, 
USA) at 4,500 rpm for 10 min and washed by sterile saline water (approximately 1.5% 
or 0.85% NaCl depend on bacteria). The bacterial pellet was cleaned and resuspended 
in sterile saline water and centrifuged at 4,500 rpm for 10 min again. After the last 
centrifuge, the supernatant was drained and then bacterial pellet was resuspended in 
Mueller-Hinton broth (MHB) (Merck KGaA, Darmstadt, Germany) (the preparation is 
showed in Table 6 following manufacturer’s protocol) that contained NaCl as 
appropriate. The resuspended bacterial cells in Mueller-Hinton broth was determined 
the optical density at 600 nm that corresponding to the bacterial density at 108 CFU/ml 
by using the spectrophotometer. Then bacterial density at 108 CFU/ml was diluted by 
Mueller-Hinton broth (supplemented NaCl as appropriate) for 105 CFU/ml that ready 
to use for MIC and MBC determination. 
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Table 6. The preparation of Mueller-Hinton broth. 
Mueller-Hinton Broth Ingredients 
Supplemented 0.85% NaCl Supplemented 1.5% NaCl 
Distilled water (ml) 1000 1000 
Mueller-Hinton broth (g) 21 21 
NaCl (g) 8.5 15 
Directions: All ingredients are suspended in glass bottle and sterilized by autoclaving 
at 121 °C for 10 minutes, cool to 40-45 °C and stored in 4 °C and protected from direct 
light. 
2.1.7.3.2. Preparation of purified synthetic cod piscidin solution 
The preparation of synthetic cod piscidin for determination of minimal 
inhibitory and bactericidal concentration was modified from Noga et al. (2009) Briefly 
the dry material of synthetic cod piscidin after freeze drying was resuspended in 0.01% 
acetic acid and determined the concentration by using a Quant-iTTM protein assay kit 
(Invitrogen, U.S.A). Finally synthetic cod piscidin was diluted to desired concentration 
in 0.2% (w/v) bovine serum albumin/0.01% (v/v) acetic acid and stored in -80 °C until 
use. 
2.1.7.3.3. Determination of minimal inhibitory concentrations (MICs) of purified 
synthetic cod piscidin 
Determination of minimal inhibitory concentrations (MICs) of synthetic cod 
piscidin various 12 bacteria was performed by using a microtitre broth dilution assay in 
96 microtitre plate (Becton Dickinson, France) that was modified from Fernandes et al. 
(2002). In this experiment the MIC of synthetic cod piscidin was defined as the lowest 
synthetic cod piscidin concentration that inhibits bacterial growth by 50% compared to 
the positive control (bacterial cells without peptide). Bacteria suspension in logarithm 
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phase of growth was prepared following 2.1.7.3.1. Ninety microliter of suspended 
bacterial cells in Mueller-Hinton broth (MHB), contained 105 CFU/ml was added into 
each well of sterile 96 well-microtitre plate for triplicate and followed by adding with 
10 µl of a two-fold serial dilution of synthetic cod piscidin, diluted in 0.2% (w/v) 
bovine serum albumin/0.01% (v/v) acetic acid (Noga et al., 2009). The plate was 
incubated at the appropriate temperature (Table 5) until the optical density at 540 nm 
(Microplate reader, Fluostar optima, BMG Labtech GmbH, Offenburg, Germany) 
reached 0.2 in the positive control well, contained 90 µl of suspended bacteria and 10 
µl of synthetic cod piscidin diluent. In addition, three negative controls were included: 
i) 90 µl of MHB and 10 µl of synthetic cod piscidin diluent, ii) 90 µl of MHB and 10 
µl of synthetic cod piscidin solution, and iii) 100 µl of MHB only. 
2.1.7.3.4. Determination of minimal bactericidal concentration (MBC) of purified 
synthetic cod piscidin 
All 12 bacteria in Table 5 were determined the minimal bactericidal 
concentration (MBC), performed as described by Fernandes and Smith (2002). Briefly, 
90 µl of washed bacteria containing approximately 105 CFU/ml in Mueller-Hinton 
broth (MHB) (supplemented 0.85 % or 1.5 % NaCl as appropriate) were added to each 
well in a 96-well microtitre plate and then 10 µl of two-fold serial dilution of synthetic 
cod piscidin was added. The control well contained 90 µl of suspended bacterial cells 
in MHB and 10 µl of synthetic cod piscidin diluents. Three negative controls were 
performed: i) 90 µl of MHB and 10 µl of synthetic cod piscidin diluent, ii) 90 µl of 
MHB and 10 µl of synthetic cod piscidin solution, and iii) 100 µl of MHB. All sample 
and controls were performed for triplicate. The microtitre plates were incubated in 
optimal temperature (Table 5) for 24 h and then the samples were plated on TSA 
(supplemented 0.85% or 1.5% NaCl as appropriate) and incubated at the appropriate 
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temperature (Table 5). The MBC was considered as the lowest concentration of 
synthetic cod piscidin that prevented colony forming on trypticase soy agar plates after 
incubation for 24 h. 
2.1.8. Haemolytic activity 
In the haemolytic activity of peptides was followed modification from 
Fernandes et al. (2002). Freshly blood (syringes were coated with peparin 150 IU/ml of 
blood) from Atlantic cod was washed with 10 mM phosphate buffered saline (PBS; 0.9 
% (w/v) NaCl, pH 7.4) in the sterile centrifuge tube by centrifugation to remove the 
leucocytes (buffy coat) and plasma (supernatant). The cleaned erythrocytes are 
deposited in bottom of centrifuge tube was resuspended in PBS and packed by 
centrifugation at 800 g for 10 min at 4 °C, and then 2 % (v/v) packed cell volume of 
cod erythrocytes were diluted in PBS that ready to test with peptide. Three 
antimicrobial peptides; synthetic cod piscidin, cecropin P1, and melittin were diluted to 
give a range of concentrations from 0.2-1.4 µM. Eleven microliters of each 
concentration of each peptide was added to 100 µl of a 2 % packed cod erythrocytes in 
PBS and incubated at 37 °C for 30 min. The controls were performed: i) negative 
controls, 100 µl of 2 % packed cod erythrocytes in PBS and 11 µl of PBS, ii) positive 
controls, 100 µl of 2 % packed cod erythrocytes and 11 µl of 0.2 % (v/v) Triton X-100. 
All the samples and controls were centrifuged at 1000 g for 5 min at room temperature. 
One hundred microliters of the supernatant from each sample was diluted with 800 µl 
of PBS and measured the absorbance at 540 nm (Microplate reader, Fluostar optima, 
BMG Labtech GmbH, Offenburg, Germany). The percentage of haemolytic activity of 
peptide was calculated from the ratio of absorbance of sample and positive control, 
(Absorbance540 nm of sample/Absorbacne540 nm of positive control)×100. 
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2.1.9. Cytoplasmic membrane permeabilization assay 
The membrane permeability assay was modified from Park et al. (2006) and 
Bunthof et al. (2001). A commercial viability and counting kit, the LIVE/DEAD 
BacLight kit was used (Invitrogen, USA). Two molecular DNA stains SYTO 9 (green 
fluorescence) can pass intact cell membranes and propidium iodide (PI) (red 
fluorescence) can only enter through permeabilized cell membranes. The bacterial cells 
stained by the fluorescent dyes were analysed by flow cytometry (Cell counter, 
Beckman Coulter, USA) to show the fluorescence intensity of untreated and synthetic 
cod piscidin treated bacterium cells. Gram-positive bacterium P. citreus was selected 
to test in this assay. Briefly, bacterium colonies were picked from freshly overnight 
culture on TSA plates and inoculated in flasks, contained 50 ml of TSB (supplemented 
1.5% NaCl), and incubated at 20 °C until reaching to exponential phase. Bacterium 
cells were harvested by centrifugation, washed with sterile saline (supplemented 1.5% 
NaCl) and resuspended in MHB (supplemented 1.5% NaCl). Ninety microliter of 
bacterial suspension containing 1×106 CFU/ml in MHB were mixed with 10 µl of 
different concentrations of synthetic cod piscidin, while 10 µl of MHB was added in 
90 µl of bacterial suspension was considerate as control. All samples and control were 
incubated at 20 °C for 1 h, followed by adding 100 µl of working solution (1.5 µl of 
SYTO 9, 1.5 µl of PI, and 497 µl of sterile saline 1.5% NaCl) of LIVE/DEAD 
BacLight bacterial viability and counting kit and incubated at room temperature for 15 
min. Then the fluorescence intensity of samples and control was determined by a flow 
cytometer (Cell Lab Quanta, Beckman Coulter, USA). 
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2.1.10. Kinetic assay 
The kinetic study, inhibiting rate of bacterium cell growth after incubation with 
synthetic cod piscidin was performed by fluorescence labeling using the commercial 
LIVE/DEAD BacLight bacterial viability and counting kit (Invitrogen, USA) 
following method 2.1.9. analysed by flow cytometry ( Cell lab Quanta, Beckman 
Coulter, USA). Briefly, P. citreus cells at exponential phase were washed with sterile 
saline 1.5 % NaCl and resuspended in MHB (supplemented 1.5% NaCl) to 106 
CFU/ml. 90 µl of bacterium suspension were mixed with 10 µl of synthetic cod 
piscidin at 0.08 µM to against P. citreus, while the control was 90 µl of bacterium 
suspension and 10 µl of MHB. All samples and control were incubated at 20°C until 
the indicated times and then incubated with an equal volume of working solution 
(2.1.9.) of LIVE/DEAD BacLight bacterial viability and counting kit before analyzing 
the fluorescence intensity by flow cytometric analysis. 
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2.2. Results 
2.2.1. Peptide analysis 
Cod piscidin protein sequence and piscidin family member were aligned, the 
results showed higher conserved amino acids found at the signal peptide region 
amongst modern fish species than mature and prodomain regions. In contradiction, less 
conserved amino acids can be identified along entire sequence of cod piscidin 
compared to piscidin from higher teleost (Fig. 7). The phylogenetic relationships of 
protein sequences of teleost piscidin orthologues was reconstructed. The result showed 
piscidin from Atlantic cod (Gadus morhua) is clustered together with large yellow 
croaker (Larimichthys crocea), while they are separated from other teleosts in 
Acanthopterygii superorder. In addition piscidin from all three grouper species are 
grouped together that more relate with mandarin fish (Siniperca chuatsi) than bass 
(Morone chrysops, Morone saxatilis, and Morone chrysops × Morone saxatilis,) (Fig. 
8). This result suggest that piscidin from Atlantic cod, belong to Paracanthopterygii 
superorder has the same ancestor with teleosts piscidins from Acanthopterygii 
superorder, and it showed to have high relatively with the large yellow croaker (Fig. 
9). 
Figure 7. The ClustalW multiple sequence alignment of piscidin protein 
sequences from teleost. The identities are represented by dots, while dashes 
denote the gaps indicated to maximize alignments. 
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Figure 8. The phylogenetic relationship between teleost piscidins.  
The phylogenetic relationship between teleost piscidins were analysed by Maximum 
likelihood of piscidin protein sequences using ATGC: Montpellier bioinformatics 
platform (PhyML) and performed the tree by MEGA 4. The number of each node 
indicated the percentage of bootstrapping after 100 replications and the aligned 
piscidin proteins sequences were showed in Fig. 7. 
 31 
 
Figure 9. The taxonomic relationships of teleosts, were obtained protein 
sequences of piscidins. All fish pictures were obtained from FishBase; 
http://www.fishbase.org/ and FAO; http://www.fao.org/fishery/en). 
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2.2.2. Peptide purification 
The synthetic peptide was purified by C18 reversed phase HPLC with 
water/acetonitrile gradient (Fig. 10, top panel), the interested fractions were collected 
from retention time of 35 to 50 min which are highly peaks. The fractions 35-50 were 
freeze dried by lyophilizing and resuspended in 0.01% acetic acid for antibacterial 
activity assay and SDS-PAGE. The antibacterial activity of fractions 35-50 against P. 
citreus using two layers radial diffusion assay (Fig. 10, bottom panel) was found that 
highly inhibition clear zone areas from retention time of 44 and 45 min. Moreover, 
SDS-PAGE result was performed a single band in retention time of 44 and 45 min 
which are indicated molecular mass below 3.4 kDa (Fig. 11) after coomassie staining. 
Fractions 44 and 45 of purified synthetic cod piscidin were collected to analyze 
molecular mass by the matrix-assisted laser desorption/ionization time-of-flight 
(MALDI-TOF MS) mass spectrum that showed a signal to molecular ion 
approximately at 2527 Da (Fig. 12) that similar to theoretical molecular weight (2527 
Da) of obtained sequence, FIHHIIGWISHGVRAIHRAIHG. Finally yield of pure 
synthetic cod piscidin of fractions 44 and 45 were polled and quantified the 
concentration before determining the antibacterial activity assays. 
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Figure 10. The purification of synthetic cod piscidin. 
The purification was used C18 reversed-phase column for HPLC using 0.1% 
trifluoroacetic acid in acetonitrite and 0.1% trifluoroacetic acid in distilled water as 
gradient, as indicated by dotted line, and the solid line represents the absorbance at 280 
nm (top panel). The bottom panel shows the antibacterial activity of the various 
fractions, as determined by two-layer radial diffusion assay against the Gram-positive 
bacterium P. citreus. The peak eluting at 44 and 45 min (chromatogram) had the 
highest antibacterial activity (histogram). 
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Figure 11. SDS-PAGE analysis of the active fractions of purified synthetic cod 
piscidin. 
The active fractions were tested antibacterial activity against P. citreus. Lane 1: low-
molecular weight protein markers; lane 2: non purified synthetic cod piscidin; lane 3: 
fraction 44 of purified synthetic cod piscidin by HPLC; lane 4: fraction 45 of purified 
synthetic cod piscidin by HPLC. Each lane contains 2.5 µl of sample, except the 
markers (7 µl). The numbers left side showed the molecular mass of the markers in 
kilodaltons (kDa). 
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Figure 12. MALDI-TOF MS analysis of purified synthetic cod piscidin. 
The fraction 44 and 45 from purified synthetic cod piscidin that are showed by 
monoisotopic mass result. A top picture is represented molecular mass of fraction 44 
(2527.20 Da) and a bottom picture is represented molecular mass of fraction 45 
(2527.35 Da). While peak at 1570.67 Da is corresponded to internal standard of mass 
adjustment. 
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2.2.3. Bacterial growth curve and their density 
The preliminary study of bacterial growth determination and the determination 
of their density were used for antibacterial activity of antibacterial agents in this 
research. The investigation of bacterial growth was taken by optical density at 600 nm 
at indicated times (Appendex 1) during lag phase, log phase, and stationary phase of 
various Gram-positive and Gram-negative bacteria after incubation. The result showed 
the time during exponential phase of growth curve of M. lysodeikticus, S. aureus 
ATCC 9144, and E. coli ATCC 25922, incubated at 37 °C that appear short lag and log 
phase, the duration of their exponential phase of all three bacteria were selected at 3 
hours after inoculation. While, P. citreus and P. immobilis were incubated at 20 °C 
showed the slow growth rate that were selected the duration of their exponential phase 
at 14 hours after inoculation. Whereas, The growth curve of C. glutamicum ATCC 
13032, V. anguillarum NCIMB 2133, V. anguillarum VI-F-258-3, V. anguillarum, A. 
salmonicida NCIMB 1102, Y. ruckeri NCIMB 2196, and Y. ruckeri VI 3629 were 
performed the duration of their exponential phase at 8 hours after inoculation (Table 
7). 
Moreover, the relationship of optical density at 600 nm and bacterial density 
was calculated from linear regression equation, shown in Appendix 2. The results 
showed the optical density at 600 nm corresponding to 108 CFU/ml of each bacterium 
was provided in Table 7. Four bacteria; M. lysodeikticus, P. citreus, C. glutamicum 
ATCC 13032, and V. anguillarum shows optical density at 600 nm were 0.550, 1.022, 
0.500, and 0.500, respectively that corresponding to 108 CFU/ml. For other Gram-
positive and Gram-negative bacteria displayed optical density at 600 nm between rang 
0.100-0.275 that corresponding to 108 CFU/ml. 
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Table 7. Bacterial strains and the duration of their exponential phase after 
inoculation and the optical density at 600 nm corresponding to 108 CFU/ml of 
bacterial density. 
Bacterial strains Exponential phase (h) OD600 corresponding to 
108 CFU/ml 
M. lysodeikticus  3 0.550 
P. citreus  14 1.022 
S. aureus ATCC 9144 3 0.150 
C. glutamicum ATCC 13032 8 0.500 
E. coli ATCC 25922 3 0.156 
V. anguillarum NCIMB 2133  8 0.200 
V. anguillarum VI-F-258-3  8 0.100 
V. anguillarum  8 0.500 
A. salmonicida NCIMB 1102  8 0.156 
Y. ruckeri NCIMB 2196  8 0.121 
Y. ruckeri VI 3629  8 0.160 
P. immobilis  14 0.275 
The values represented as average of three replications for each sample. The growth 
and cell density curves were showed in Appendix 1 and 2, respectively. 
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2.2.4. Antibacterial activity of synthetic cod piscidin against 
various bacteria and its haemolytic activity against cod 
erythrocytes 
The minimal inhibitory concentrations (MICs) and minimal bactericidal 
concentration (MBC) of synthetic cod piscidin against all 12 test bacterial strains were 
showed in Table 8. The result showed synthetic cod piscidin has more active against 
Gram-positive bacteria than Gram-negative bacteria with exception of V. anguillarum 
and P. immobilis. In addition, the MIC values of ranged between 0.04-5 µM of 
synthetic cod piscidin were performed against all four Gram-positive bacteria i.e. M. 
lysodeikticus, P. citreus, S. aureus ATCC 9144, C. glutamicum ATCC 13032 and two 
Gram-negative; V. anguillarum, P. immobilis. While the MBC were 4 times higher 
than MICs for P. citreus and 2 times higher than MICs for C. glutamicum ATCC 
13032 and P. immobilis, while MBC of other tested bacteria were more than 5 µM. 
The haemolytic activity of synthetic cod piscidin and cecropin P1 were showed 
percentage of haemolysis constantly around 30% from the lowest concentrations of 0.2 
µM until highest concentrations of 1.4 µM. While, percentage haemolysis of melittin 
against cod erythrocytes was increased following the increasing of its concentrations, 
over 0.8 µM of melittin performed completely lytic for cod erythrocytes (Fig. 13). 
Therefore synthetic cod piscidin has less haemolytic effect than melittin which has a 
strong haemolystic activity against cod erythrocytes. 
 39 
Table 8. The minimal inhibitory and bactericidal concentrations of synthetic cod 
piscidin against twelve test bacteria. 
Bacterial strains Gram 
MICs 
(µM)a 
MBC 
(µM)b 
M. lysodeikticus  + 1.25-2.5 >5 
P. citreus  + 0.04-0.08 1.25 
S. aureus ATCC 9144 + 2.5-5 >5 
C. glutamicum ATCC 13032 + 0.63-1.25 2.5 
E. coli ATCC 25922 - >5 >5 
V. anguillarum NCIMB 2133 - >5 >5 
V. anguillarum VI-F-258-3 - >5 >5 
V. anguillarum  - 2.5-5 >5 
A. salmonicida NCIMB 1102 - >5 >5 
Y. ruckeri NCIMB 2196 - >5 >5 
Y. ruckeri VI 3629 - >5 >5 
P. immobilis  - 0.63-1.25 2.5 
The values were represented as average of triplicate of each sample. 
a MIC, was defined as the lowest synthetic cod piscidin concentration that inhibits 
bacterial growth by 50% compared to the positive control (bacteria without peptide). 
MIC curves of synthetic cod piscidin against various bacteria were showed in 
Appendix 3. 
b MBC, was considered as the lowest concentration of synthetic cod piscidin that 
prevented colony forming on TSA plates after incubation for 24 h. 
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Figure 13. The haemolytic activity of peptides against erythrocytes of Atlantic 
cod.  
The tested peptides were diluted to desired concentrations and incubated with a 2% 
(v/v) of cod erythrocytes for 30 min at 37 °C and performed for triplicate. Values were 
represented as means±standard error (vertical bars), n=3. 
2.2.5. Permeabilization of bacterium cells treated by 
synthetic cod piscidin 
 Gram-positive bacterium P. citreus cells were treated with synthetic cod 
piscidin with two difference concentrations of 0.08 µM (upper value of MICs interval) 
and 1.25 µM (MBC). The result of treated bacterial cells with synthetic cod piscidin 
(0.08 µM and 1.25 µM) was observed fluorescence intensity of internalized PI 
(florescent red) in bacterial cells after analyzed by flow cytometric analysis. The 
percentages of permeable cells were increased with concentration of synthetic cod 
piscidin from 0.08 µM (44.45% permeabilised cells) to 1.25 µM (87.33% 
permeabilised cells) after incubation for 1 h. Therefore synthetic cod piscidin able to 
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form the pore in bacterium membranes that allowed small molecule of PI enter the 
bacterium cells. While, the control (bacteria without synthetic cod piscidin) was less 
observed PI fluorescence (1.83% permeabilised cells) in dead bacterium cells but 
showed higher percentage of live cells (89.19% intact cells) labeled with fluorescent 
green of SYTO 9 after incubation for 1 h (Fig. 14 and Fig. 15). 
 
Figure 14. Permeabilization assay of synthetic cod piscidin against P. citreus. 
This assay was observed by PI (fluorescence red labeled permeabilized cells) and 
SYTO 9 (fluorescence green labeled intact cells) labeling and analyzed by using flow 
cytometric analysis. A, control was P. citreus cells suspension were incubated without 
synthetic cod piscidin; B, P. citreus cells suspension were incubated with synthetic cod 
piscidin at 0.08 µM (upper value of MIC interval); and C, P. citreus cells suspension 
were incubated with synthetic cod piscidin at 1.25 µM (MBC). While, the particles 
outside the defined regions were considered as unknown. 
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Figure 15. The average percentage of intact and permeabilized P. citreus cells. 
The intact cells were labeled by SYTO 9 (fluorescence green), whereas permeabilized 
P. citreus cells were indicated by PI internalization (fluorescence red) after incubated 
at 20 °C for 1 h with two concentration of synthetic cod piscidin (0.08 and 1.25 µM). 
While the control was performed as test bacteria without synthetic cod piscidin (0 µM 
of synthetic cod piscidin) and analyzed by using flow cytometric analysis. Each sample 
and control was performed for triplicate, values are represented as means±standard 
error (vertical bars); n=3. 
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2.2.6. Kinetic study 
 The kinetic study of synthetic cod piscidin against Gram-positive bacterium P. 
citreus cells which is the highly sensitive bacterium to synthetic cod piscidin were 
investigated inhibiting growth rate after treated with synthetic cod piscidin at 0.08 µM 
(upper value of MIC interval) with increasing of incubation times (Fig. 16) by flow 
cytometric analysis. The results found at 0 h after incubation with synthetic cod 
piscidin was found percentage of live bacterium cells was around 90 % and the live 
bacterium cells were decreased with increasing time. After 1 h of incubation, treated 
bacterium cells with synthetic cod piscidin were showed constant percentage of live 
bacterium cells of 43.96 %, 43.29 %, 52.16 % and 44.31 % of 1, 3, 6, 24 h, 
respectively incubation times. While the control, untreated bacterium cells with 
peptide showed approximately 90 % of live bacterium cells every indicated times (0-
24 h) after incubation at 20 °C. 
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Figure 16. The kinetic of synthetic cod piscidin against P. citreus. 
 
The kinetic was analyzed by 
flow cytometric analysis. The 
pictures A, C, E, G, I, and K 
were untreated bacterium cells 
(control) at 0, 0.5, 1, 3, 6, and 
24 h, respectively after 
incubation. While B, D, F, H, J, 
and L were treated bacterium 
cells with 0.08 µM (upper value 
of MIC interval) at 0, 0.5, 1, 3, 
6, and 24 h, respectively after 
incubation. The particles 
outside the defined regions 
were considered as unknown. 
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2.3. Discussion 
2.3.1. Sequence analysis 
In this study found the piscidin from G. morhua, Paracanthopterygii superorder 
has relationships with teleost piscidins from Acanthopterygii superorder. Most of 
protein sequences of piscidin are taxonomic relationship within Acanthopterygii 
superorder with exceptions of L. crocea sequence that is high relatively with G. 
morhua. This result similar with Fernandes et al. (2010) that showed separation of 
piscidin sequences of G. morhua and L. crocea from the other teleosts. The reason that 
cod piscidin is different from the other teleost piscidins from Acanthopterygii 
superorder might be caused by longer evolutionary distance than those teleosts. 
However, piscidins were found in many teleost species, especially the members in 
Acanthopterygii superorder. In addition, nine species of teleosts from the 36 species 
tested were showed immunopositive with anti-piscidin 1 antibody that found in 
families Moronidae (M. saxatilis, M. chrysops, M. saxatilis × M. chrysops, 
Dicentrarchu labrax), Serranidae (Epinephelus niveatus), Sciaenidae (Leiostomus 
xanthurus, Micropogonias undulates), Siganidae (Siganus rivulatus), Belontidae 
(Trichogaster leeri), and Cichlidae (Oreochromis niloticus) which are the members in 
order Perciformes (Silphaduang et al., 2006). Moreover, Corrales et al. (2010) detected 
strong piscidin 4-positive cells in tissues (gill, intestine, stomach) of importance 
commercially fish including hybrid striped bass (M. saxatilis × M. chrysops), white 
bass (M. chrysops), striped bass (M. saxatilis), european seabass (D. labrax), and 
giltheaad seabream (Sparus aurata) by immunohistochemistry. The most of piscidins 
are found expression in order Perciformes of Acanthopterygii superorder, and in this 
study showed piscidin also was found in G. morhua that belong to family Gadidae of 
Paracanthopterygii superorder. Piscidins are present in many commercially importance 
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fish in aquaculture that included Atlantic cod, a new important cultured commercial 
fish species. 
2.3.2. Peptide purification and identification 
The synthetic cod piscidin was synthesized by using a sequence, 
FIHHIIGWISHGVRAIHRAIHG that was characterized from Atlantic cod and 
performed a molecular mass 2527 Da by MALDI-TOF MS analysis. The synthetic cod 
piscidin sequence contained 22 amino acid and showed highly histidin and isoleucine 
rich in its sequence that similar with 22 amino acid piscidin 1, 2, 3 were isolated from 
mast cells of hybrid striped bass and highly conserved histidine-rich and 
phenylalanine-rich (Silphaduang and Noga, 2001). Moreover, Lauth et al. (2002) 
discovered two isoforms of 22 amino acid moronecidin from skin and gills of hybrid 
striped bass that performed molecular mass 2543 and 2571 Da and highly histidine 
content in their sequences. While, piscidin 4 from gill of hybrid striped bass is 44 
residues peptide with molecular mass 5329 Da that has highly homologous at its N-
terminus to piscidin 1, 2, and 3 (Noga et al., 2009). 
2.2.3. Bacterial growth curve and their density 
In this study, all 12 bacteria were determined the growth curve which is the 
relationship between optical density at 600 nm with indicated times to select the 
appropriate incubation time during their exponential phage that used for antibacterial 
activity assays. Three bacteria including M. lysodeikticus, S. aureus ATCC 9144 and 
E. coli ATCC 25922 were incubated at 37 °C that growth faster than other bacterial 
which were cultured at 20 °C, while P. citreus and P. immobilis grew quite slow 
(Appendix 1). 
The drop plate technique was applied in this study to determine the cell density, 
antibacterial activity of minimal bactericidal concentration and kinetic profile of 
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synergism. Duo to Chen et al. (2003) and Herigstad et al. (2001) performed the 
advantages of drop plate technique for bacterial density estimation; 1) saving the time 
for plating and colony counting process, 2) more accurately by counting under stereo-
microscope, 3) less material cost because in one agar plate could be investigated for 
triplicate of each dilution, and 4) more space in incubator for the plates incubation. 
However, the error from drop plate technique might be caused by colonies overlapping 
that result to incorrect colony counting (Herigstad et al., 2001), and the pipetting 
during serial dilution process and dropping on agar plate also was considered as the 
weakness of this method. 
2.2.4. Antimicrobial activity of synthetic cod piscidin 
The synthetic cod piscidin has ability to inhibit the bacterial growth by in vitro 
study using MIC and MBC estimation. The results performed synthetic cod piscidin 
seem to be more potential against Gram-positive bacteria (M. lysodeikticus, P. citreus, 
S. aureus ATCC 9144, and C. glutamicum ATCC 13032) than Gram-negative bacteria 
at micromolar concentration level. However, two Gram-negative bacteria including V. 
anguillarum and P. immobilis were inhibited in vitro growth by synthetic cod piscidin. 
Six Gram-negative bacteria including E. coli ATCC 25922, V. anguillarum NCIMB 
2133, V. anguillarum VI-F-258-3, A. salmonicida NCIMB 1102, Y. ruckeri NCIMB 
2196, and Y. ruckeri VI 3629 showed MIC and MBC values more than 5 µM, however 
if the synthetic cod piscidin is increased the test concentration then bacterial growth 
might be inhibited at higher than 5 µM. In this study was demonstrated the 
antibacterial activity of synthetic cod piscidin high potentiate against some bacteria, 
however there were many researches have been investigated ability of piscidins from 
fishes that resulted broad spectrum against bacteria, parasite, fungal and event virus. 
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Silphaduang and Noga (2001) isolated piscidin 1,2,3 from mast cell of hybrid 
striped bass that showed killing both Gram-positive and Gram-negative bacteria which 
are fish pathogens (e.g., S. iniae, A. salmonicida, and V. alginolyticus) and human 
pathogens (e.g., S. aureus, E. coli, Streptococcus faecalis, and Pseudomonas 
aeruginosa) that showed MIC in range 0.8-12.5 µg/ml, while MBC in range 1.6-25 
µM. Moreover, piscidin 4 was isolated from healthy hybrid striped bass that have 
ability to against both fish and human pathogens e.g., S. iniae (MIC and MBC 12.5-25 
µg/ml), Listonella agnuillarum (MIC and MBC 6.3 µg/ml), S. aureus (MIC and MBC 
6.3-12.5 µg/ml) and E. coli (MIC and MBC 50 µg/ml) (Noga et al., 2009). Moreover 
Lauth et al. (2002) performed antibacterial activity of synthetic amidated moronecidin 
against both Gram-positive bacteria (e.g., M. luteus and methicilin-resistant S. aureus 
showed MIC 10-20 and 1.25-2.5 µM, respectively) and Gram-negative bacteria (e.g., 
E. coli, A. hydrophila, V. cholera, Yersinia enterocolitica showed MIC 5-10, >20, 2.5-
5, 2.5-5 µM, respectively) that similar to antibacterial activity of bass moronecidin also 
showed by inhibiting bacterial growth, S. iniae, E. coli, Y. enterocoliticus, and Serratia 
sonnei at MIC in range 2.5-5 µM (Lauth et al., 2005). These published papers were 
confirmed that piscidins as a potent broad spectrum against bacteria growth by in vitro 
study. Unfutually, in this study determined the MIC and MBC of synthetic cod piscidin 
at maximum concentration of 5 µM that were not enough to inhibit in vitro growth of 
most of Gram-negative bactria (E. coli ATCC 25922, V. anguillarum NCIMB 2133, V. 
anguillarum VI-F-258-3, A. salmonicida NCIMB 1102, Y. ruckeri NCIMB 2196, and 
Y. ruckeri VI 3629). This result similar to Sun et al. (2007) study that reported the 
antibacterial activity of synthetic amidated piscidin from mandarin fish (S. chuatsi) 
able to against many Gram-negative bacteria at more than 5 µM of piscidin 
concentration including Aeromonas (MICs 10->160 µM and MBCs 20->160 µM), V. 
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anguillarum (MICs 20-80 µM and MBCs 40-160 µM), Y. ruckeri (MICs 20-40 µM 
and MBCs 40-80 µM), and E. coli (MICs 5-10 µM and MBCs 10-20 µM). However in 
this study was found sensitive Gram-negative bacterium P. immpbilis was inhibited 
growth at MICs 0.63-1.25 and MBC 2.5 µM that can be suggested that this bacterium 
might have difference in cellular membranes and pathogenicity from other tested 
Gram-negative bacteria that performed MIC and MBC more than 5 µM. 
Interestingly, piscidin was confirmed its ability to kill parasites by Coloni et al. 
(2008) that reported the antiparasitic activity of piscidin 2 from mast cells of hybrid 
striped bass able to against marine fish ectoparasites (Cryptocaryon irritans, 
Trichodina sp., and Amyloodinium ocellatum) and freshwater fish ectoparasites 
(Ichthyophthirius multifiliis), the protozoacidal concentration (PCmin, lowest 
concentration where at least one parasite died) showed against Trichodina, 
Cryptocaryon theront, Amyloodinium dinospore, and Ichthyophthirius theront of 
peptide concentration 12.5-100, 12.5, 6.3-12.5, and 6.3 µg/ml, respectively. 
In addition piscidin also showed potential against fungal that was reported by 
Sung et al. (2008), piscidin 2 inhibit growth of human pathogenic fungal including 
Malassezia furfur, Trichosporon beigelii, and Candida albicans at MICs of 6.25, 1.56, 
and 6.25 µM, respectively. Moreover, moronecidin from bass also performed against 
filamentous fungi including Neurospora crassa (MICs 1.56-3.12 µM), Aspergillus 
fumigates (MICs 50-100 µM), Fusarium oxysporum (MICs 0.78-1.56 µM), Fusarium 
culmorum (MICs 0.39-0.78 µM), and yeast, C. albicans, C. glabrata, C. lusitania, and 
C. tropicalis at MICs 10-20 µM (Lauth et al., 2002). 
Piscindins performed antibacterial, antifungal, antiparasitic activity, and 
surprisingly also showed antiviral activity property that piscidin-1N, 1H, 2, and 3 from 
hybrid striped bass were reported ability to reduce the infectivity of channel catfish 
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virus and frog virus3 at I50 (the concentration of piscidin that reduce viral infectivity by 
50%) of 4-11 µM and 13-16 µM, respectively (Chinchar et al., 2004). 
In this study demonstrated the ability of synthetic cod piscidin for antibacterial 
activity. Moreover, many reports were supported that piscidin has antimicrobial 
properties that able to against bacteria, fungal, parasite, and event virus. Therefore 
piscidin is appropriate to be a novel antimicrobial agent that might be applied for 
medication in aquaculture industry. 
2.3.5. Haemolytic activity against cod erythrocytes 
In this study was found synthetic cod piscidin has less haemolytic activity than 
mellitin, but still the same with cecropin P1. The piscidin 1, 2, and 3 from mast cells of 
hybrid striped bass were showed more haemolytic than magainin 2 but still less than 
melittin, approximately 10 µg/ml of piscidin 1, piscidin 2 and 100 µg/ml of piscidin 3 
started lytic human erythrocytes (Silphaduang and Noga, 2001). While, four 
concentrations of bass hepcidin including 5.5, 11, 22, and 44 µM were incubated with 
hybrid striped bass erythrocytes at 37 °C showed no haemolysis was observed at 5.5 
and 11 µM after incubation for 4 h, while 0.4-2.5 % haemolysis was showed after 3 h 
of incubation with 22 and 44 µM of bass hepcidin (Lauth et al., 2005). Moreover, 
moronecidin from hybrid striped bass has no haemolytic effect against human and 
sheep red blood cells below concentrations of 2.5 µM, while the concentrations over 5 
µM were observed haemolysis until reach to 20-80 µM which were found 100% lytic 
human red blood cells, and over 10 µM also was observed haemolysis of sheep red 
blood cells (Lauth et al., 2002). In addition amidated and non-amidated fish piscidin 1 
and 3 at concentration of 100 µg/ml was observed haemolytic effect against human red 
blood cells (Chekmenev et al., 2006). 
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2.3.6. Permeability of synthetic cod piscidin 
In this study used commercial LIVE/DEAD BacLight bacterial viability and 
counting kit to observe proportion of live and dead bacterium cells that were labeled 
by SYTO9 and PI and analyzed by using flow cytometric analysis. PI is a small 
molecule that can enters permeabilized cells and bound with double stranded nucleic 
acid and result red fluorescence, while intact bacterium cells were labeled fluorescence 
green of SYTO 9. In this study was found internal PI fluorescence in permeabilized P. 
citreus cells after incubated with 0.08 and 1.25 µM of synthetic cod piscidin that 
confirmed the ability of this peptide could disrupt bacteria membrane and allowed PI 
molecule enters inside the cells. However, some population of test bacterium cells 
could not be detected fluorescent labeled cells that identified as intermediate cells 
which might be caused by peptide still disrupting and forming the pore on bacterium 
cells membrane. Piscidin was demonstrated that its amphiphatic α-helical structure that 
contained high positively charge have potential to permeabilise bacterial membrane 
(Cotten et al., 2009). Cod piscidin was used in this study also has positive net charge 
and can be adopted the same structure (Rungsri et al. unpublished). Moreover piscidin 
2 damaged fugal, C. albicans plasma membrane potential that was found accumulation 
of DiBAC4(3) (binds to lipid-rich intracellular components) in depolarized cells and 
also found pore forming in fungal membrane by detection fluorescent 1,6-diphenyl-
1,3,5-hexatriene (associate with phospholipids within cytoplasmic membrane), lead to 
the releasing of intracellular cellular component and ions from the fungal cells (Sung et 
al., 2008). From these data were confirmed that main target of synthetic cod piscidin is 
the cytoplasmic membranes by pore formation which is the common mechanism of 
cationic antimicrobial peptides. For example, Park et al. (2006) investicated higher 
internalized PI fluorescence intensity of cationic antimicrobial peptide P5 treated S. 
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aureus cells than untreated and antibiotic chloramphenicol (act on inhibiting 
translation) treated cells by flow cytometric analysis. However, some antimicrobial 
peptides have no effect to cytoplasmic membrane, Buforin II could bind to DNA and 
RNA that lead to inhibiting cellular functions (Park et al., 1998a) and indolicidin that 
showed inhibiting DNA and protein synthesis (Subbalakshmi and Sitaram, 1998). 
Interestingly, in this study found synthetic cod piscidin at 0.08-1.25 µM could 
permeabilised P. citreus membrane that lead to bacterium growth inhibition around 44-
87 % by using flow cytometric analysis. Moreover, the percentage of haemolytic 
activity of this peptide showed less haemolysis around 30 % against cod erythrocytes 
by peptide concentration in range 0.2-1.4 µM which covered the concentrations of 
0.08-1.25 µM that can lysis P. ctreus cells for around 44-87 %. 
2.3.7. Kinetic study 
In this study, the bacterium growth was inhibited by synthetic cod piscidin at 
0.08 µM (upper value of MIC interval) that was found the percentage of live cells were 
decreased from 0 h (89.81 %) to 30 min (75.47 %) and until 1 h (43.96 %) after 
incubation with peptide. In addition from 3, 6, and 24 h after incubation, treated 
bacterium cells with synthetic cod piscidin were showed constant percentage of live 
bacterium cells of 43.29 %, 52.16 % and 44.31, respectively. Lauth et al. (2002) 
observed kinetic of synthetic amidated white bass moronecidin against S. aureus and 
found 90 % of bacterium cells were killed within 1 and 10 min after incubated with 6 
µM (2 times MIC) and 3 µM, respectively at 37 °C, however lower incubation 
temperature at 30 °C showed reducing of killing rate than at 37 °C either at 3 or  6 µM 
of peptide concentrations. Therefore the kinetic of antimicrobial peptides are 
dependent on time, peptide concentration, incubation temperature, and tested bacterial 
strain. 
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Chapter 3. Synergistic activity of synthetic 
piscidin from Atlantic Cod (Gadus morhua L.) 
with other antibiotic agents 
3.1. Materials and Methods 
3.1.1. Test bacteria 
Three Gram-negative bacteria including V. anguillarum VI-F-258-3, A. 
salmonicida NCIMB 1102, Y. ruckeri VI 3629 and two Gram-positive bacteria 
including M. lysodeikticus, and P. citreus were selected study the synergistic activity 
of combined synthetic cod piscidin and antibiotic agents. All five bacteria were 
cultured under the appropriate conditions (Table 5) until reached to exponential phase. 
Suspended bacterial cells in media were washed and prepared following 2.1.7.3.1. 
Cleaned bacterial cells of 105 CFU/ml in saline Mueller-Hinton broth (supplemented 
NaCl as appropriate) were used for the determination of the MIC and MBC of 
antibacterial agents alone and in combination. 
3.1.2. Preparation of antibacterial agents for antibacterial 
assays 
Four antibiotic agents that are common use in aquaculture industry were used 
for synergistic activity study including: oxolinic acid, oxytetracycline hydrochloride, 
sulfadiazine/trimethoprim combination (combined as 5 parts of sulfadiazine to 1 part 
of trimethoprim) and all antibiotic agents are of commercial origin from Sigma-
Aldrich. The antibiotic stock solution was prepared by using a modification from 
Bruun et al. (2000) based on the National Committee for Clinical Laboratory Standard 
(NCCLS). Briefly, the antibiotic solutions were prepared by weighting for desired 
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amount and dissolving into specific diluent of each antibiotic, and then mixed for 
homogenous solution by vortex mixer. The diluent was sterile water for 
oxytetracycline hydrochloride, 0.1 M NaOH for oxolinic acid and sulfadiazine, and 
0.05 M HCl for trimethoprim. In addition oxolinic acid and sulfadiazine/trimethoprim 
solutions were adjusted the pH in range between 6-8 with 1 M NaOH and 1 M HCl. 
Then the final concentration of NaOH and HCl in antibiotic solutions including 0.0006 
M NaOH and 0.004 M HCl for oxolinic acid, while 0.0004 M NaOH and 0.003 M HCl 
for sulfadiazine/trimethoprim. All antibiotic solutions were stored in 1.5 ml sterile 
micro tube in -80 °С. 
The preparation of synthetic cod piscidin was following 2.1.7.3.2 base on Noga 
et al. (2009) method, briefly the synthetic cod piscidin was resuspended in 0.2% (w/v) 
bovine serum albumin/0.01% (v/v) acetic acid and kept in -80 °C until use for 
antibacterial activity test. 
3.1.3. The determination of minimal inhibitory and bacterici-
dal concentration of antibacterial agents 
Determination of minimal inhibitory concentrations (MICs) and minimal 
inhibitory bactericidal concentration (MBC) of antibiotic agents and synthetic cod 
piscidin against test bacteria was followed 2.1.7.3.3 and 2.1.7.3.4 that was modified 
from Fernandes et al.(2002). Briefly, test bacterium cells 105 CFU/ml in Mueller-
Hinton broth (supplemented NaCl as appropriate) was added into each well of 96 well-
microtitre plates in volume 90 µl and mixed with 10 µl of two-fold serial dilutions of 
antibacterial agent for triplication. The positive control well, contained 90 µl of 
suspended bacteria and 10 µl of antibacterial agent diluent. Moreover, three negative 
controls were included: i) 90 µl of MHB and 10 µl of antibacterial agent diluent, ii) 90 
µl of MHB and 10 µl of antibacterial agent solution, and iii) 100 µl of MHB. The 
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plates were incubated under appropriate condition of each test bacteria (Table 5) until 
the optical density at 540 nm reached to 0.2 in the positive control well. MIC was 
determined as the lowest antibacterial agent concentration that inhibits bacterial 
growth by 50% compared with the positive control. 
In addition the MBC was observed by plating out from each well of 96 well-
microtitre plates after incubation with antibacterial agents at appropriate temperature 
for 24 h on trypticase soy agar plate, contained 0.85% or 1.5% NaCl as appropriate. 
MBC was considered as the lowest concentration of antibacterial agent that prevented 
colony forming on trypticase soy agar after incubation for 24 h in appropriate 
temperature. 
3.1.4. Synergistic activity of peptide-antibiotic combination 
Synergistic study of combined synthetic cod piscidin with conventional 
antibiotics was determined following the modification from Park et al. (2006). The 
method involves determining the individual MIC of antibiotic and synthetic cod 
piscidin alone as well as the MIC of antibiotic and synthetic cod piscidin in the 
combination that was tested in 96 well plates. The initial concentration of the 
combined antibiotic and synthetic cod piscidin was based on the individual MIC of 
antibiotic and synthetic cod piscidin. Briefly, 90 µl of suspended bacterial cells 105 
CFU/ml in MHB (supplemented NaCl as appropriate) was added in each well of 96 
well plate and followed by adding of two-fold serial dilutions of combined 
antibacterial agents. The positive control well was contained 90 µl of bacterial cells 
105 CFU/ml in MHB and 10 µl of antibacterial agent diluent. Three negative controls 
were performed: i) 90 µl of MHB and 10 µl of antibacterial agent diluent, ii) 90 µl of 
MHB and 10 µl of combined antibacterial agent solution, and iii) 100 µl of MHB. 
Each test sample and control were performed in triplicate, the plate was incubated at 
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appropriate temperature until the optical density at 540 nm of positive control well 
reached to 0.2. The MIC was determined as the lowest antibacterial agent 
concentration that inhibits bacterial growth by 50% compared with the positive control 
(Fernandes et al., 2002). The synergistic activity was assessed by determining the 
fractional inhibitory concentration (FIC) index. The FIC index is used as an indicator 
of synergistic activity of two antibacterial agents combination and calculated according 
to the equation: 
FIC index= FICA+FICB= [A]/MICA+[B]/MICB 
Where [A] and [B] are the MIC of drug A and drug B in the combination, 
MICA and MICB are the MIC of drug A and drug B alone, and FICA and FICB are the 
FIC of drug A and drug B. The FIC indexes are interpreted as follows: ≤0.5, good 
synergism; 1.0, additive; and >4.0, antagonism (Yan and Hancock, 2001). 
3.1.5. Kinetics of synergism 
Determination of kinetic of combined oxolinic acid and synthetic cod piscidin 
which showed synergistic activity against V. anguillarum VI-F-258-3 was evaluated 
base on Fernandes et al. (2002) by using the viable count of drop plate technique 
(Herigstad et al., 2001). Briefly, 90 µl of suspended bacteria approximately 105 
CFU/ml in MHB (supplemented 1.5% NaCl) was mixed with 10 µl of combined 
antibacterial agents solution contained 0.031 µM of oxolinic acid and 5 µM of 
synthetic cod piscidin (based on MIC of individual oxolinic and synthetic cod piscidin 
against V. anguillarum VI-F-258-3) in 96 well plate and then incubated at 20 °C for 
indicated times. The kinetic study was monitored at 0 min, 30 min, 1h, 2h, 3h, 6h, 12h, 
and 24h after combined antibacterial agents addition. As controls including positive 
control which is the mixing between 90 µl of suspended bacteria approximately 105 
CFU/ml in MHB and 10 µl of antibacterial agent diluents, while three negative 
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controls including: i) 90 µl of MHB and 10 µl of antibacterial agent diluent, ii) 90 µl of 
MHB and 10 µl of antibacterial agent solution, and iii) 100 µl of MHB. The test 
samples and controls were performed in triplicate. The sample each indicated time 
after incubation was diluted in media base on 10 fold serial dilution and plating by 
using drop plate technique (Herigstad et al., 2001) on TSA that contained 1.5% NaCl 
and the agar plates were incubated at 20 °C. The bacterial colonies were counted under 
stereo microscope following the bacterium colony density standard should be between 
in rang 30-300 colonies on agar plate. Finally the bacterial density (CFU/ml) was 
plotted with indicated time after incubation. 
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3.2. Results 
3.2.1. Antibacterial activity against test bacteria 
The minimal inhibitory concentrations (MICs) of synthetic cod piscidin showed 
more active to Gram-positive bacteria in range of MICs 0.04-2.5 µM than Gram-
negative bacteria that showed MIC >5 µM. The MBC of synthetic cod piscidin against 
all tested bacteria were higher than 5 µM (maximal tested concentration) with 
exception of P. citreus was showed MBC of 1.25 µM (Table 9). 
The MICs and MBC of antibiotic agents against Gram-positive bacteria (M. 
lysodeikticus and P. citreus) and Gram-negative bacteria (V. anguillarum VI-F-258-3, 
A. salmonicida NCIMB 1102, and Y. ruckeri VI 3629) were provided in Table 10. The 
result was found that MIC of sulfadiazine/trimethoprim against M. lysodeikticus was 
performed highest concentration (MICs 32-64 µM), while showed more active against 
P. citreus (MICs 0.031-0.063 µM). However, the MBC result of 
sulfadiazine/trimethoprim was not active against all five tested bacteria. The 
antibacterial activity of oxolinic acid and oxytetracycline hydrochloride was performed 
in range 0.016-0.5 µM against all five tested bacteria. The MBC of oxolinic acid also 
showed ineffective against P. citreus (MBC >64 µM), whereas very active against A. 
salmonicida NCIMB 1102 (MBC 0.063 µM). Moreover, MBC of oxytetracycline 
hydrochloride performed more active A. salmonicida NCIMB 1102 (MBC 1 µM) than 
other tested bacteria. 
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Table 9. The minimal inhibitory and bactericidal concentrations of synthetic cod 
piscidin against five test bacteria. 
Bacteria MIC (µM)a MBC (µM)b 
M. lysodeikticus  1.25-2.5 >5 
P. citreus  0.04-0.08 1.25 
V. anguillarum VI-F-258-3 >5 >5 
A. salmonicida NCIMB 1102 >5 >5 
Y. ruckeri VI 3629 >5 >5 
The values were represented as average of triplicate of each sample. 
a MIC, was defined as the lowest synthetic cod piscidin concentration that inhibits 
bacterial growth by 50% compared to the positive control (bacteria without peptide). 
b MBC, was considered as the lowest concentration of synthetic cod piscidin that 
prevented colony forming on TSA plates after incubation for 24 h. 
.
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Table 10. The minimal inhibitory and bactericidal concentrations of antibiotic agents against various bacteria. 
Oxolinic acid Oxytetracycline hydrochloride Sulfadiazine/trimethoprim 
Bacteria 
MIC (µM)a MBC (µM)b MIC (µM)a MBC (µM)b MIC (µM)a MBC (µM)b 
M. lysodeikticus 0.125-0.25 1 0.063-0.125 8 32-64 >64 
P. citreus 0.25-0.5 >64 0.031-0.063 16 0.031-0.063 >64 
V. anguillarum VI-F-258-3 0.016-0.031 1 0.016-0.031 8 0.5-1 >64 
A. salmonicida NCIMB 1102 0.016-0.031 0.063 0.031-0.063 1 2-4 32 
Y. ruckeri VI 3629 0.031-0.063 16 0.125-0.25 32 0.5-1 >64 
The values were represented as average of triplicate of each sample. 
a MIC, The MIC was defined as the lowest antibiotic concentration that inhibits bacterial growth by 50% compared to the positive control 
(bacteria without peptide). The MIC curve was showed in Appendix 4. 
b MBC, The MBC was considered as the lowest concentration of antibiotics that prevented colony forming on TSA plates after incubation 
for 24 h. 
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3.2.2. Synergistic activity  
Five strains of bacteria including two Gram-positive bacteria; M. lysodeikticus, 
P. citreus and three Gram-negative bacteria; Y. ruckeri VI 3629, V. anguillarum VI-F-
258-3, A. salmonicida NCIMB 1102 were tested synergistic activity of antibiotic-
peptide combination. The synergistic activity results were showed in Table 11, 12, and 
13 that reported moderate synergism for combined oxolinic acid and synthetic cod 
piscidin against V. anguillarum VI-F-258-3; combined oxytetracycline hydrochloride 
and synthetic cod piscidin against V. anguillarum VI-F-258-3, A. salmonicida NCIMB 
1102; and combined sulfadiazine/trimethoprim and synthetic cod piscidin against M. 
lysodeikticus, A. salmonicida NCIMB 1102, Y. ruckeri VI 3629. In contrast, no 
synergistic activity of all three test antibioticss with synthetic cod piscidin was found 
against P. citreus. However, additive activity of combined oxolinic acid and synthetic 
cod piscidin against P. citreus showed one-fold decreasing in the MICs of individual 
antibacterial agent in combination. 
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Table 11. The FIC index of combined oxolinic acid and synthetic cod piscidin against test bacteria. 
MIC (µM) MIC of combination (µM) 
Bacteria 
oxolinic acid piscidin oxolinic acid, piscidin 
FIC index Interpretation 
M. lysodeikticus 0.125-0.25 1.25-2.5 0.125-0.25, 1.25-2.5 2.0 Additive 
P. citreus 0.25-0.5 0.04-0.08 0.125-0.25, 0.02-0.04 1.0 Additive 
V. anguillarum VI-F-258-3 0.016-0.031 >5 0.008-0.016, 1.25-2.5 <0.7 Moderate synergism 
A. salmonicida NCIMB 1102 0.016-0.031 >5 >0.031, >5 >3.0 Antagonism 
Y. ruckeri VI 3629 0.031-0.063 >5 0.031-0.063, 2.5-5 <1.5 Additive 
FIC index= FICA+ FICB = [A]/ MICA+[B]/ MICB , where [A] and [B] are the MICs of drug A and drug B in the combination, MICA and 
MICB are the MICs of drug A and drug B alone, and FICA and FICB are the FICs of drug A and drug B. FIC index are interpreted as 
follow: ≤0.5,good synergism; 1.0,additive; and >4.0,antagonism. 
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Table 12. The FIC index of combined oxytetracycline hydrochloride and synthetic cod piscidin against test bacteria. 
MIC (µM) MIC of combination (µM) 
Bacteria 
oxytetracycline 
hydrochloride 
piscidin 
oxytetracycline 
hydrochloride, piscidin 
FIC index Interpretation 
M. lysodeikticus 0.063-0.125 1.25-2.5 0.031-0.063, 0.63-1.25 1.0 Additive 
P. citreus 0.031-0.063 0.04-0.08 0.031-0.063, 0.04-0.08 2.0 Additive 
V. anguillarum VI-F-258-3 0.016-0.031 >5 0.008-0.016, 1.25-2.5 <0.7 Moderate synergism 
A. salmonicida NCIMB 1102 0.031-0.063 >5 0.016-0.031, 1.25-2.5 <0.7 Moderate synergism 
Y. ruckeri VI 3629 0.125-0.25 >5 >0.25, >5 >3.0 Antagonism 
FIC index= FICA+ FICB = [A]/ MICA+[B]/ MICB , where [A] and [B] are the MICs of drug A and drug B in the combination, MICA and 
MICB are the MICs of drug A and drug B alone, and FICA and FICB are the FICs of drug A and drug B. FIC index are interpreted as 
follow: ≤0.5,good synergism; 1.0,additive; and >4.0,antagonism. 
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Table 13. The FIC index of sulfadiazine/trimethoprim and synthetic cod piscidin against test bacteria. 
MIC (µM) MIC of combination (µM) 
Bacteria 
Sulfadiazine 
/trimethoprim 
piscidin sulfadiazine/trimethoprim, 
piscidin 
FIC index Interpretation 
M. lysodeikticus 32-64 1.25-2.5 8-16, 0.63-1.25 0.7 Moderate synergism 
P. citreus 0.031-0.063 0.04-0.08 >0.063, >0.08 >4 Antagonism 
V. anguillarum VI-F-258-3 0.5-1 >5 0.5-1, 2.5-5 <1.5 Additive 
A. salmonicida NCIMB 1102 2-4 >5 1-2, 1.25-2.5 <0.7 Moderate synergism 
Y. ruckeri VI 3629 0.5-1 >5 0.25-0.5, 1.25-2.5 <0.7 Moderate synergism 
FIC index= FICA+ FICB = [A]/ MICA+[B]/ MICB , where [A] and [B] are the MICs of drug A and drug B in the combination, MICA and 
MICB are the MICs of drug A and drug B alone, and FICA and FICB are the FICs of drug A and drug B. FIC index are interpreted as 
follow: ≤0.5,good synergism; 1.0,additive; and >4.0,antagonism. 
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3.2.3. The kinetic of oxolinic acid and synthetic cod piscidin 
in combination against V. anguillarum VI-F-258-3 
In this study, the combination of oxolinic acid and synthetic cod piscidin 
showed moderate synergistic activity against V. anguillarum VI-F-258-3 that was 
determined kinetic profile at indicated times after incubation (Fig. 17). The 
concentration of combined oxolinic acid and synthetic cod piscidin were considered 
base on the combination between MIC of individual agent, then in combination 
contained oxolinic acid 0.031 µM (the upper interval MIC value) and 5 µM of 
synthetic cod piscidin (MIC > 5 µM). The result showed bacterium cells density were 
increased a little bit from 0 h to 2 h after incubated with combined oxolinic acid and 
synthetic cod piscidin at 20 °C. And then bacterium cells density were started 
decreasing after 2 h until 24 h after incubation. While a control was incubated with 
absence of combined oxolinic acid and synthetic cod piscidin that found bacterium 
cells density were increased from 0 h until 24 h after incubation at 20 °C. 
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Figure 17. The kinetic of combined oxolinic acid and synthetic cod piscidin 
against V. anguillarum VI-F-258-3. 
A, suspended V. anguillarum VI-F-258-3 approximately 105 CFU/ml in MHB were 
incubated with combined oxolinic acid (0.031 µM) and synthetic cod piscidin (5 µM) 
and plated on TSA for indicated times after incubation at 20°C. B, the control was 
contained V. anguillarum VI-F-258-3 suspension approximately 105 CFU/ml in MHB 
and incubated without combined antibacterial agents. Values are represented as 
means±standard error (vertical bars); n=3. 
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3.3. Discussion 
3.3.1. Minimal inhibitory and bactericidal concentration of 
antibacterial agents 
In this study found the individual MIC of synthetic cod piscidin were observed 
by MIC in rang 0.04-2.5 µM against 2 Gram-positive bacteria (M. lysodeikticus and P. 
citreus), while MIC of synthetic cod piscidin against all 3 strains of Gram-negative 
bacteria (V. anguillarum VI-F-258-3, A. salmonicida NCIMB 1102, and Y. ruckeri VI 
3629) were more than 5 µM. In addition, only MBC of synthetic cod piscidin against 
P. citreus was investigated of 1.25 µM of peptide concentration, whereas the MBC of 
other test bacteria performed more than 5 µM of peptide concentration. However, the 
antibacterial activity of synthetic cod piscidin against different bacterial stains was 
discussed in the Chapter 2. 
The antibacterial activity of conventional antibiotics; oxolinic acid, 
oxytetracycline hydrochloride, and sulfadiazine/trimethoprim were investigated MIC 
and MBC against various bacteria. In this study; ineffective antibacterial activity was 
found for sulfadiazine/trimethoprim combination against all five tested bacteria under 
consideration of MBC value. Moreover MICs of sulfadiazine/trimethoprim showed 
high concentration against M. lysodeikticus (MICs 32-64 µM), however the MICs of 
sulfadiazine/trimethoprim were 0.031-0.063 µM against P. citreus. Oxolinic acid 
showed very active antibacterial activity against A. salmonicida NCIMB 1102 (MBC 
0.063 µM), whereas ineffective antibacterial against P. citreus (MBC >64 µM). There 
are many reports for antibacterial activity of antibiotics used in aquaculture was 
investigated. Schmidt et al. (2000) observed the MICs of some antibiotics used in 
Danish aquaculture; oxolinic acid, sulfadiazine/trimethoprime combination 5:1, and 
oxytetracycline against Y. ruckeri (MICs of 2-8, 0.05-1, and 2-8 µg/ml, respectively), 
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and Aromonas resistant strains (MICs of 4-16, 205->1,024, and 32-256 µg/ml, 
respectively). Moreover, Bruun et al. (2000) reported the MICs of some antibiotics 
used in aquaculture; oxolinic acid, potentiated sulfadiazine (five parts sulfadiazine to 
one part trimethoprim), and oxytetracycline hydrochloride against F. psychrophilum 
(MICs of 0.13-0.25, 16-32, and 0.063-0.13 mg/ml, respectively), E. coli ATCC 25922 
(MICs of 0.032-0.063, 2-4, and 1-2 mg/ml, respectively), S. aureus ATCC 29213 
(MICs of 0.5-1, 1-2, and 0.25-1 mg/ml, respectively), and Pseudomonas aeruginosa 
ATCC 27853 (MICs of 16-32, 256-512, and 8-16 mg/ml, respectively). In this study, 
sulfadiazine/trimethoprim combination showed ineffective antibacterial activity 
against all five tested bacteria that similar with report of Bruun et al. (2000), showed 
less antibacterial effect of potentiated sulfadiazine against Pseudomonas aeruginosa 
ATCC 27853 (MICs 256-512 µg/ml) and F. psychrophilum NCIMB 1947 (MICs 16-
32 µg/ml). Moreover, Myhr et al. (1991) have been tested MIC90 of antibiotics 
consisting enrofloxacin, flumequine, oxolinic acid, nitrofurazolidone, oxytetracycline, 
and combined trimethoprim-sulfadiazine against V. anguillarum serovar O1 and O2 
strains by using drug microdilution method, the result showed MIC of 
nitrofurazolidone (MICs of 1-4 µg/ml) higher than MIC of combined trimethoprim-
sulfadiazine (MIC of 0.5 µg/ml) and another antibiotics (oxytetracycline, oxolinic acid, 
enrofloxacin, and flumequine, MIC <0.5 µg/ml) against both V. anguillarum serovar. 
However, in the present was found antibiotic resistant bacteria that reported by 
Akinbowale et al. (2006) investigated antibiotics (e.g., oxolinic acid, trimethoprime 
potentiated sulfonamide, and oxytetracycline) resistance in isolated bacteria from 
aquaculture (e.g., fish and crustaceans farming) and environment sources in Australia 
was found antibiotic resistance is common in isolated bacteria, for examples; Vibrio 
spp. resistance to oxytetracycline (while, no resistance to trimethoprime potentiated 
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sulfamethoxazole and oxolinic acid), Aeromonas spp. resistance to oxolinic acid, 
oxytetracycline, and trimethoprime potentiated sulfamethoxazole, Edwardsiella tarda 
resistance to oxytetracycline (susceptible to oxolinic acid and trimethoprime 
potentiated sulfamethoxazole), and Staphylococcus spp., Micrococcus spp. resistannce 
to oxolinic acid. From these supporting reports indicate that the antibiotics resistance 
bacteria were found in aquatic environment, caused by antibiotic used in aquaculture 
activity. It is possible that the antibiotic resistant gene from aquatic microorganisms 
might be transferred to terrestrial pathogens that might be caused of difficult to treat 
and prevent the diseases invading in terrestrial animals. 
3.3.2. Synergistic study of synthetic cod piscidin and antibio-
tics combination 
In this study was investigated the synergistic activity in vitro of synthetic cod 
piscidin from Atlantic cod with the conventional antibiotics, including oxolinic acid, 
oxytetracycline hydrochloride, and sulfadiazine/trimethoprim, which are amongst the 
most important antibiotic group for treatment and prevention of bacterial diseases in 
aquaculture. Interestingly, moderate synergy was found in this studies that showed FIC 
index <0.7 for combined synthetic cod piscidin with oxolinic acid, oxytetracycline 
hydrochloride, and sulfadiazine/trimethoprim against various strains of fish pathogenic 
bacteria including V. anguillarum VI-F-258-3, A. salmonicida NCIMB 1102, and Y. 
ruckeri VI 3629. The combination of antibacterial agents in this study showed 
synthetic cod piscidin can reduce the concentration of conventional antibiotics required 
to inhibit bacterial growth of most of test bacteria after combination. Many 
publications have been reported that combination of two antibacterial agents including 
combined antimicrobial peptide with antimicrobial peptide and also combined 
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antimicrobial peptide and antibiotic could enhanced their antimicrobial activity against 
various strains of bacteria than using antimicrobial peptide or antibiotic alone.  
The synergistic interaction between the conventional antibiotic agent 
chloramphenicol and peptide A3 (sequenced from the N-terminus of Helicobacter 
pylori ribosomal protein L1) was found that their antibacterial activity in vitro against 
both Gram-negative and Gram-positive bacteria (S. aureus, P. aeruginosa, and E. coli) 
increased 2-8 fold more than using peptide A3 or antibiotic chloramphenicol alone 
(Park et al., 2004). Moreover Park et al. (2006) showed highest S. aureus membrane 
permeability of combined cationic antimicrobial peptide P5 with chloramphenical 
when compared with untreated and antibiotic treated bacterium cells by detection 
internalized PI fluorescence intensity using flow cytometric analysis. Another research 
was reported that synergy between pleurocidin and the lactic acid bacterial 
antimicrobial peptides destroyed outer membranes of bacterial (Luders et al., 2003). 
From these reports were confirmed that the combination of antimicrobial peptide and 
antibiotic could enhance their antibacterial activity and membrane permeability when 
compared with individual activity. Importantly the combination of antimicrobial 
peptide and antibiotic may solve the problem of antibiotic resistant bacteria that was 
supported by in vitro study of synergistic activity of combined antibacterial peptides 
nisin (produced by Lactococcus lactis) and ranalexin (isolated from bullfrog skin) with 
several antibiotics e.g., amoxycillin, and amoxicillin-clavulanate. The result was 
showed the killing activity was enhanced by against methicillin-resistant 
Staphylococcus aureus (MRSA) which is the resistance antibacterial treatment 
(Giacometti et al., 2000a). The similarly by Cirioni et al. (2006) showed the strong 
synergistic activity between α-helical antimicrobial peptides, magainin II and cecropin 
A with vancomycin that were investigated FIC indexes in range 0.312-0.458 against S. 
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ureus ATCC 25923, and S. aureus with intermediate resistance to vancomycin. In this 
study was observed moderate synergism of synthetic cod piscidin in combination with 
clinically used antibiotics in aquaculture. Unfortunately, antagonisms were found for 
combined synthetic cod piscidin with oxolinic acid, oxytetracycline hydrochloride, and 
sulfadiazine/trimethoprim against A. salmonicida NCIMB 1102, Y. ruckeri VI 3629, 
and P. citreus, respectively. This antagonism result was similar to Ulvatne et al. (2001) 
that reported no synergy between antibacterial peptides (P18, P15, P12, P9, and P6) 
and antibiotics (ampicillin, vancomycin, erythromycin, gentamicin, tetracycline, 
ciprofloxacin, and rifampicin) with exception of synergistic combination of 
antibacterial peptide P9 with ampicillin against S. aureus ATCC 25923, whereas, 
strong synergism of all antibacterial peptides (P18, P15, P12, P9, and P6) and 
erythromycin was observed against E. coli ATCC 25922. In addition, two synergistic 
interactions were investigated between enrofloxacin with antimicrobial peptides 
alamethicin and surfactin (FIC indexes were 0.75 and 0.56, respectively), whereas two 
indifference interactions were found between enrofloxacin with antimicrobial peptides 
globomycin and gramicidin S (FIC indexes were 1 for both) against Mycoplasma 
pulmonis (Fehri et al., 2007). In this study not only antagonism were found but 
additive activity also were investigated. The antagonism and additive activity might be 
caused by competition or alteration of biding site between combined antibacterial 
agents and particular binding site on bacterial cell. Moreover, Mueller-Hinton medium 
contained high ionic strength (Yan and Hancock, 2001) that might disrupt the 
combination of antibacterial agents and inhibit their antibacterial activity that might 
lead to additive and antagonistic activity of peptide-antibiotic combination. In addition, 
Fernandes et al., (2010) have mentioned that glycine residue at position 7 (Fig. 6) in 
amphipathic structure of cod piscidin might disrupt its function, which might related to 
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reducing of its antibacterial activity or ability to combine with antibiotics. Similar with 
Silphaduang and Noga (2001) report that a glycine substituted for histidin at position 
17 of piscidin 3 might disrupt the its amphipathic α-helix structure and lead to reducing 
of its haemolytic and antibacterial activity as well.  
Not only combination between antimicrobial peptide and antibiotic that can 
enhance their antibacterial activity but the combination between antibacterial peptides 
also can increase antibacterial activity when compared with individual activity. Lauth 
et al. (2005) showed synergism antibacterial activity of combined hepcidin and 
moronecidin, purified from the gills of hybrid striped bass against S. iniae, E. coli, Y. 
enterocolitica, and S. sonnei, the FIC indices were between 0.5-0.75 that were 
indicated good to moderate synergy. Moreover Luders et al. (2003) investigated the 
strong synergy between pleurocidin with antimicrobial peptides (produced by lactic 
acid bacteria); curvacin A, pediocin PA-1, and sakacin P that showed FIC indexes 
0.19-0.5 against Gram-positive Listeria ivanovii Li4 and Gram-negative E. coli ATCC 
14763 with exception of combined pleurocidin with sakacin P, showed FIC index 1. 
Thus, the interaction between antimicrobial peptide with antibiotic is 
potentially enhancing antimicrobial activity and can supporting useful for 
antimicrobial therapy. Moreover, the combination of them could reduce the antibiotic 
concentration and increased antibacterial activity against antibiotic resistant bacteria by 
in vitro study. Therefore the combination of antimicrobial peptide and antibiotic might 
be used to manage antibiotic resistant bacteria problem and control bacterial diseases 
in aquaculture in the future. 
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Chapter 4. Conclusions 
Disease management is crucial in the aquaculture industry, and to date it 
involves the usage of antibiotics to treat and prevent diseases, especially bacterial 
infections. However, there is a growing concern over the problems caused by 
conventional antibiotics in environment (e.g., bacteria resistant to multiple antibiotics). 
Therefore, it is crucial to reduce the usage of conventional antibiotics or find 
alternative novel antibacterial agents to manage bacterial diseases and antibiotic-
resistant bacteria. Antimicrobial peptides are produced from multicellular organisms 
and have the ability to kill and inhibit bacteria via different mechanisms, namely by 
permeabilizing the bacterial cell membrane or disrupt cell metabolism. Therefore the 
antimicrobial peptides are considered as an attractive new alternative to conventional 
antibiotics. One significant advantage of antimicrobial peptides is that they have a 
broad spectrum of activity and can synergise with other antibiotics. In this thesis, I 
have investigated the antibacterial activity in-vitro of synthetic cod piscidin from 
Atlantic cod against different Gram-positive and Gram-negative bacteria and found 
synthetic cod piscidin to be more active against Gram-positive bacteria than Gram-
negative bacteria with exception of V. anguillarum and P. immobilis. Interestingly, the 
permeabilization assay of synthetic cod piscidin against P. citreus revealed that this 
peptide permeabilized the bacterial membrane at its MICs and MBC values. Synthetic 
cod piscidin showed similar haemolytic activity to cecropin 1 and was less haemolytic 
than melittin against cod erythrocytes. Moreover, the synergistic activity in-vitro of 
synthetic cod piscidin was investigated with the conventional antibiotics, including 
oxolinic acid, oxytetracycline hydrochloride, and sulfadiazine/trimethoprim 
combination, which are amongst the most important antibiotics used for prevention of 
bacterial diseases in aquaculture. The peptide-antibiotic combination were tested 
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against two Gram-positive bacteria; M. lysodeikticus, P. citreus and three Gram-
negative bacteria; Y. ruckeri VI 3629, V. anguillarum VI-F-258-3, A. salmonicida 
NCIMB 1102 which are common fish pathogens. The synergistic activity results 
showed moderate synergism for combined oxolinic acid and synthetic cod piscidin 
against V. anguillarum VI-F-258-3; combined oxytetracycline hydrochloride and 
synthetic cod piscidin against V. anguillarum VI-F-258-3, A. salmonicida NCIMB 
1102; and combined sulfadiazine/trimethoprim and synthetic cod piscidin against M. 
lysodeikticus, A. salmonicida NCIMB 1102, Y. ruckeri VI 3629. In contrast, no 
synergistic activity of all three test antibiotics with synthetic cod piscidin was found 
against P. citreus. The data show that synthetic cod piscidin can reduce the 
concentration of conventional antibiotics required to inhibit bacterial growth of fish 
pathogenic bacteria (Y. ruckeri VI 3629, V. anguillarum VI-F-258-3, and A. 
salmonicida NCIMB 1102). These results provide a better insight into the mode of 
action of synthetic cod piscidin and suggest that it could be explored as an alternative 
antibiotic, which may be used in disease control management in commercial 
aquaculture systems in the future. 
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Appendix 1 
Growth curve of various bacteria 
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Figure A1.1. Growth curve of M. lysodeikticus that showed the relationship between 
optical densities at 600 nm and indicated times after incubation with appropriate 
culture conditions. The error bars were represented the standard error values for the 
average of triplicate. Red circle is indicated time during exponential phase. 
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Figure A1.2. Growth curve of P. citreus that showed the relationship between optical 
densities at 600 nm and indicated times after incubation with appropriate culture 
conditions. The error bars were represented the standard error values for the average of 
triplicate. Red circle is indicated time during exponential phase. 
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Figure A1.3. Growth curve of S. aureus ATCC 9144 that showed the relationship 
between optical densities at 600 nm and indicated times after incubation with 
appropriate culture conditions. The error bars were represented the standard error 
values for the average of triplicate. Red circle is indicated time during exponential 
phase. 
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Figure A1.4. Growth curve of C. glutamicum ATCC 13032 that showed the 
relationship between optical densities at 600 nm and indicated times after incubation 
with appropriate culture conditions. The error bars were represented the standard error 
values for the average of triplicate. Red circle is indicated time during exponential 
phase. 
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Figure A1.5. Growth curve of E. coli ATCC 25922 that showed the relationship 
between optical densities at 600 nm and indicated times after incubation with 
appropriate culture conditions. The error bars were represented the standard error 
values for the average of triplicate. Red circle is indicated time during exponential 
phase. 
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Figure A1.6. Growth curve of V. anguillarum NCIMB 2133 that showed the 
relationship between optical densities at 600 nm and indicated times after incubation 
with appropriate culture conditions. The error bars were represented the standard error 
values for the average of triplicate. Red circle is indicated time during exponential 
phase. 
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Figure A1.7. Growth curve of V. anguillarum VI-F-258-3 that showed the relationship 
between optical densities at 600 nm and indicated times after incubation with 
appropriate culture conditions. The error bars were represented the standard error 
values for the average of triplicate. Red circle is indicated time during exponential 
phase. 
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Figure A1.8. Growth curve of V. anguillarum that showed the relationship between 
optical densities at 600 nm and indicated times after incubation with appropriate 
culture conditions. The error bars were represented the standard error values for the 
average of triplicate. Red circle is indicated time during exponential phase. 
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Figure A1.9. Growth curve of A. salmonicida NCIMB 1102 that showed the 
relationship between optical densities at 600 nm and indicated times after incubation 
with appropriate culture conditions. The error bars were represented the standard error 
values for the average of triplicate. Red circle is indicated time during exponential 
phase. 
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Figure A1.10. Growth curve of Y. ruckeri NCIMB 2196 that showed the relationship 
between optical densities at 600 nm and indicated times after incubation with 
appropriate culture conditions. The error bars were represented the standard error 
values for the average of triplicate. Red circle is indicated time during exponential 
phase. 
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Figure A1.11. Growth curve of Y. ruckeri VI 3629 that showed the relationship 
between optical densities at 600 nm and indicated times after incubation with 
appropriate culture conditions. The error bars were represented the standard error 
values for the average of triplicate. Red circle is indicated time during exponential 
phase. 
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Figure A1.12. Growth curve of P. immobilis that showed the relationship between 
optical densities at 600 nm and indicated times after incubation with appropriate 
culture conditions. The error bars were represented the standard error values for the 
average of triplicate. Red circle is indicated time during exponential phase. 
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Appendix 2 
The correlation ship between bacterial densities and optical density at 600 nm 
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Figure A2.1. The relationship between cell density and optical density at 600 nm of M. 
lysodeikticus. Values are represented as means±standard error (vertical bars); n=3. The 
linear regression equation was used to calculate the bacterium cell density at particular 
optical density at 600 nm. 
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Figure A2.2. The relationship between cell density and optical density at 600 nm of P. 
citreus Values are represented as means±standard error (vertical bars); n=3. The linear 
regression equation was used to calculate the bacterium cell density at particular 
optical density at 600 nm. 
 
 82 
0
10
20
30
40
50
60
70
80
0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80
OD600
Ce
ll 
de
n
si
ty
 
(10
7  
CF
U/
m
l) CFU = 1·109OD600 - 5·107
r2 = 0.9716
Ce
ll 
de
n
si
ty
 
(10
7  
CF
U/
m
l)
 
Figure A2.3. The relationship between cell density and optical density at 600 nm of S. 
aureus ATCC 9144. Values are represented as means±standard error (vertical bars); 
n=3. The linear regression equation was used to calculate the bacterium cell density at 
particular optical density at 600 nm. 
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Figure A2.4. The relationship between cell density and optical density at 600 nm of C. 
glutamicum ATCC 13032. Values are represented as means±standard error (vertical 
bars); n=3. The linear regression equation was used to calculate the bacterium cell 
density at particular optical density at 600 nm. 
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Figure A2.5. The relationship between cell density and optical density at 600 nm of E. 
coli ATCC 25922. Values are represented as means±standard error (vertical bars); n=3. 
The linear regression equation was used to calculate the bacterium cell density at 
particular optical density at 600 nm. 
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Figure A2.6. The relationship between cell density and optical density at 600 nm of V. 
anguillarum NCIMB 2133. Values are represented as means±standard error (vertical 
bars); n=3. The linear regression equation was used to calculate the bacterium cell 
density at particular optical density at 600 nm. 
 
 84 
0
5
10
15
20
25
0.00 0.05 0.10 0.15 0.20 0.25 0.30
OD600
Ce
ll 
de
n
si
ty
 
(10
7 C
FU
/m
l) CFU = 7·108OD600 + 3·107
r2 = 0.9795
Ce
ll 
de
n
si
ty
 
(10
7 C
FU
/m
l)
 
Figure A2.7. The relationship between cell density and optical density at 600 nm of V. 
anguillarum VI-F-258-3. Values are represented as means±standard error (vertical 
bars); n=3. The linear regression equation was used to calculate the bacterium cell 
density at particular optical density at 600 nm. 
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Figure A2.8. The relationship between cell density and optical density at 600 nm of V. 
anguillarum. Values are represented as means±standard error (vertical bars); n=3. The 
linear regression equation was used to calculate the bacterium cell density at particular 
optical density at 600 nm. 
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Figure A2.9. The relationship between cell density and optical density at 600 nm of A. 
salmonicida NCIMB 1102. Values are represented as means±standard error (vertical 
bars); n=3. The linear regression equation was used to calculate the bacterium cell 
density at particular optical density at 600 nm. 
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Figure A2.10. The relationship between cell density and optical density at 600 nm of Y. 
ruckeri NCIMB 2196. Values are represented as means±standard error (vertical bars); 
n=3. The linear regression equation was used to calculate the bacterium cell density at 
particular optical density at 600 nm. 
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Figure A2.11. The relationship between cell density and optical density at 600 nm of Y. 
ruckeri VI 3629. Values are represented as means±standard error (vertical bars); n=3. 
The linear regression equation was used to calculate the bacterium cell density at 
particular optical density at 600 nm. 
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Figure A2.12. The relationship between cell density and optical density at 600 nm of 
P. immobilis. Values are represented as means±standard error (vertical bars); n=3. The 
linear regression equation was used to calculate the bacterium cell density at particular 
optical density at 600 nm. 
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Appendix 3 
Minimal inhibitory concentration of synthetic cod piscidin 
 
Figure A3.1. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of M. lysodeikticus. The optical density at 540 nm was 
determined when the positive control, bacteria without peptide reached to 0.2 after 
incubated at appropriate temperature. The MIC values are represented in rage by the 
red line indicates the inhibition of bacterial growth by 50% compared to the positive 
control. Values are represented as means±standard error (vertical bars); n=3. 
 
Figure A3.2. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of P. citreus. The optical density at 540 nm was 
determined when the positive control, bacteria without peptide reached to 0.2 after 
incubated at appropriate temperature. The MIC values are represented in rage by the 
red line indicates the inhibition of bacterial growth by 50% compared to the positive 
control. Values are represented as means±standard error (vertical bars); n=3. 
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Figure A3.3. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of S. aureus ATCC 9144. The optical density at 540 nm 
was determined when the positive control, bacteria without peptide reached to 0.2 after 
incubated at appropriate temperature. The MIC values are represented in rage by the 
red line indicates the inhibition of bacterial growth by 50% compared to the positive 
control. Values are represented as means±standard error (vertical bars); n=3. 
 
Figure A3.4. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of C. glutamicum ATCC 13032. The optical density at 
540 nm was determined when the positive control, bacteria without peptide reached to 
0.2 after incubated at appropriate temperature. The MIC values are represented in rage 
by the red line indicates the inhibition of bacterial growth by 50% compared to the 
positive control. Values are represented as means±standard error (vertical bars); n=3. 
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Figure A3.5. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of E. coli ATCC 25922. The optical density at 540 nm 
was determined when the positive control, bacteria without peptide reached to 0.2 after 
incubated at appropriate temperature. The MIC values are represented in rage by the 
red line indicates the inhibition of bacterial growth by 50% compared to the positive 
control. Values are represented as means±standard error (vertical bars); n=3. 
 
Figure A3.6. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of V. anguillarum NCIMB 2133. The optical density at 
540 nm was determined when the positive control, bacteria without peptide reached to 
0.2 after incubated at appropriate temperature. The MIC values are represented in rage 
by the red line indicates the inhibition of bacterial growth by 50% compared to the 
positive control. Values are represented as means±standard error (vertical bars); n=3. 
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Figure A3.7. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of V. anguillarum VI-F-258-3. The optical density at 
540 nm was determined when the positive control, bacteria without peptide reached to 
0.2 after incubated at appropriate temperature. The MIC values are represented in rage 
by the red line indicates the inhibition of bacterial growth by 50% compared to the 
positive control. Values are represented as means±standard error (vertical bars); n=3. 
 
Figure A3.8. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of V. anguillarum. The optical density at 540 nm was 
determined when the positive control, bacteria without peptide reached to 0.2 after 
incubated at appropriate temperature. The MIC values are represented in rage by the 
red line indicates the inhibition of bacterial growth by 50% compared to the positive 
control. Values are represented as means±standard error (vertical bars); n=3. 
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Figure A3.9. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of A. salmonicida NCIMB 1102. The optical density at 
540 nm was determined when the positive control, bacteria without peptide reached to 
0.2 after incubated at appropriate temperature. The MIC values are represented in rage 
by the red line indicates the inhibition of bacterial growth by 50% compared to the 
positive control. Values are represented as means±standard error (vertical bars); n=3. 
 
Figure A3.10. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of Y. ruckeri NCIMB 2196. The optical density at 540 
nm was determined when the positive control, bacteria without peptide reached to 0.2 
after incubated at appropriate temperature. The MIC values are represented in rage by 
the red line indicates the inhibition of bacterial growth by 50% compared to the 
positive control. Values are represented as means±standard error (vertical bars); n=3. 
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Figure A3.11. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of Y. ruckeri VI 3629. The optical density at 540 nm 
was determined when the positive control, bacteria without peptide reached to 0.2 after 
incubated at appropriate temperature. The MIC values are represented in rage by the 
red line indicates the inhibition of bacterial growth by 50% compared to the positive 
control. Values are represented as means±standard error (vertical bars); n=3. 
 
Figure A3.12. The different concentrations of synthetic cod piscidin were incubated 
with approximate 105 CFU/ml of P. immobilis. The optical density at 540 nm was 
determined when the positive control, bacteria without peptide reached to 0.2 after 
incubated at appropriate temperature. The MIC values are represented in rage by the 
red line indicates the inhibition of bacterial growth by 50% compared to the positive 
control. Values are represented as means±standard error (vertical bars); n=3. 
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Appendix 4 
Minimal inhibitory concentration of antibiotics 
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Figure A4.1. The different concentrations of antibiotics; oxolinic acid (A), 
oxytetracycline hydrochloride (B), and sulfadiazine/trimethoprim combination (C) 
were incubated with approximate 105 CFU/ml of M. lysodeikticus. The optical density 
at 540 nm was determined when the positive control reached to 0.2 after incubated at 
appropriate temperature. The MIC values are represented in rage by the red line 
indicates the inhibition of bacterial growth by 50% compared to the positive control. 
Values are represented as means±standard error (vertical bars); n=3. 
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Figure A4.2. The different concentrations of antibiotics; oxolinic acid (A), 
oxytetracycline hydrochloride (B), and sulfadiazine/trimethoprim combination (C) 
were incubated with approximate 105 CFU/ml of P. citreus. The optical density at 540 
nm was determined when the positive control reached to 0.2 after incubated at 
appropriate temperature. The MIC values are represented in rage by the red line 
indicates the inhibition of bacterial growth by 50% compared to the positive control. 
Values are represented as means±standard error (vertical bars); n=3. 
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Figure A4.3. The different concentrations of antibiotics; oxolinic acid (A), 
oxytetracycline hydrochloride (B), and sulfadiazine/trimethoprim combination (C) 
were incubated with approximate 105 CFU/ml of V. anguillarum VI-F-258-3. The 
optical density at 540 nm was determined when the positive control reached to 0.2 
after incubated at appropriate temperature. The MIC values are represented in rage by 
the red line indicates the inhibition of bacterial growth by 50% compared to the 
positive control. Values are represented as means±standard error (vertical bars); n=3. 
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Figure A4.4. The different concentrations of antibiotics; oxolinic acid (A), 
oxytetracycline hydrochloride (B), and sulfadiazine/trimethoprim combination (C) 
were incubated with approximate 105 CFU/ml of A. salmonicida NCIMB 1102. The 
optical density at 540 nm was determined when the positive control reached to 0.2 
after incubated at appropriate temperature. The MIC values are represented in rage by 
the red line indicates the inhibition of bacterial growth by 50% compared to the 
positive control. Values are represented as means±standard error (vertical bars); n=3. 
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Figure A4.5. The different concentrations of antibiotics; oxolinic acid (A), 
oxytetracycline hydrochloride (B), and sulfadiazine/trimethoprim combination (C) 
were incubated with approximate 105 CFU/ml of Y. ruckeri VI 3629. The optical 
density at 540 nm was determined when the positive control reached to 0.2 after 
incubated at appropriate temperature. The MIC values are represented in rage by the 
red line indicates the inhibition of bacterial growth by 50% compared to the positive 
control. Values are represented as means±standard error (vertical bars); n=3. 
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Appendix 5 
Minimal inhibitory concentration of combined antibiotic and synthetic cod piscidin 
 
Figure A5.1. The MIC of combined synthetic cod piscidin with oxolinic acid (A), 
oxytetracycline hydrochloride (B), and sulfadiazine/trimethoprim (C) against M. 
lysodeikticus. The red line indicates the inhibition of bacterial growth by 50% 
compared to the positive control. Values are represented as means±standard error 
(vertical bars); n=3. 
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Figure A5.2. The MIC of combined synthetic cod piscidin with oxolinic acid (A), 
oxytetracycline hydrochloride (B), and sulfadiazine/trimethoprim (C) against P. 
citreus. The red line indicates the inhibition of bacterial growth by 50% compared to 
the positive control. Values are represented as means±standard error (vertical bars); 
n=3. 
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Figure A5.3. The MIC of combined synthetic cod piscidin with oxolinic acid (A), 
oxytetracycline hydrochloride (B), and sulfadiazine/trimethoprim (C) against V. 
anguillarum VI-F-258-3. The red line indicates the inhibition of bacterial growth by 
50% compared to the positive control. Values are represented as means±standard error 
(vertical bars); n=3. 
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Figure A5.4. The MIC of combined synthetic cod piscidin with oxolinic acid (A), 
oxytetracycline hydrochloride (B), and sulfadiazine/trimethoprim (C) against A. 
salmonicida NCIMB 1102. The red line indicates the inhibition of bacterial growth by 
50% compared to the positive control. Values are represented as means±standard error 
(vertical bars); n=3. 
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Figure A5.5. The MIC of combined synthetic cod piscidin with oxolinic acid (A), 
oxytetracycline hydrochloride (B), and sulfadiazine/trimethoprim (C) against Y. 
ruckeri VI 3629. The red line indicates the inhibition of bacterial growth by 50% 
compared to the positive control. Values are represented as means±standard error 
(vertical bars); n=3. 
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